Kv1.5

1

Wu W et al. Molecular Basis of Cardiac Delayed Rectifier Potassium Channel Function and Pharmacology.
Card Electrophysiol Clin, 2016 Jun , 8 (275-84).

2

Kojima A et al. Serum albumin attenuates the open-channel blocking effects of propofol on the human Kv1.5 channel.
Eur. J. Pharmacol., 2016 Jul 15 , 783 (117-26).

3

Subramani B et al. Generation and characterization of human cardiac resident and non-resident mesenchymal stem cell.
Cytotechnology, 2016 Jan 28 , ().

4

Lee HM et al. Blockade of Kv1.5 by paroxetine, an antidepressant drug.
Korean J. Physiol. Pharmacol., 2016 Jan , 20 (75-82).

5

Ryland KE et al. Promoter Methylation Analysis Reveals That KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation.
Mol. Cancer Res., 2016 Jan , 14 (26-34).

6

Crump SM et al. Kcne4 deletion sex- and age-specifically impairs cardiac repolarization in mice.
FASEB J., 2016 Jan , 30 (360-9).

7

Doczi MA et al. Developmental expression of Kv1 voltage-gated potassium channels in the avian hypothalamus.
Neurosci. Lett., 2016 Feb 1 , 616 (182-188).

8

Ou X et al. Myricetin inhibits Kv1.5 channels in HEK293 cells.
Mol Med Rep, 2016 Feb , 13 (1725-31).

9

Kajanus J et al. Isoindolinone compounds active as Kv1.5 blockers identified using a multicomponent reaction approach.
Bioorg. Med. Chem. Lett., 2016 Apr 15 , 26 (2023-9).

10

Ahmed M et al. SGK3 Sensitivity of Voltage Gated K+ Channel Kv1.5 (KCNA5).
Cell. Physiol. Biochem., 2016 , 38 (359-67).

11

Zhao Y et al. Regulation of SCN3B/scn3b by Interleukin 2 (IL-2): IL-2 modulates SCN3B/scn3b transcript expression and increases sodium current in myocardial cells.
BMC Cardiovasc Disord, 2016 , 16 (1).

12

Ohanyan V et al. Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation.
Circ. Res., 2015 Sep 11 , 117 (612-21).

13

Wang YY et al. [Effect of ERK1/2 on rat pulmonary artery smooth muscle cells Kv1.5 channel in the process of hypoxia].
Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2015 Sep , 31 (418-21, 426).

14

Li P et al. E3 ligase CHIP and Hsc70 regulate Kv1.5 protein expression and function in mammalian cells.
J. Mol. Cell. Cardiol., 2015 Sep , 86 (138-46).

15

Kojima A et al. Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region.
Eur. J. Pharmacol., 2015 Oct 5 , 764 (622-32).

16

Asano S et al. Cecal inoculum peritonitis: An alternative model for sepsis vascular dysfunction study.
Life Sci., 2015 Nov 15 , 141 (108-18).

17

Jin SS et al. Antiarrhythmic ionic mechanism of Guanfu base A--Selective inhibition of late sodium current in isolated ventricular myocytes from guinea pigs.
Chin J Nat Med, 2015 May , 13 (361-7).

18

Fancher IS et al. Diphenyl phosphine oxide-1-sensitive K(+) channels contribute to the vascular tone and reactivity of resistance arteries from brain and skeletal muscle.
Microcirculation, 2015 May , 22 (315-25).

19

Kiper AK et al. Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea?
Pflugers Arch., 2015 May , 467 (1081-90).

20

Lloyd J et al. Pseudosaccharin amines as potent and selective KV1.5 blockers.
Bioorg. Med. Chem. Lett., 2015 Mar 7 , ().

21

Turnow K et al. Interaction of DPP10a with Kv4.3 channel complex results in a sustained current component of human transient outward current Ito.
Basic Res. Cardiol., 2015 Mar , 110 (5).

22

Yang L et al. Intravenous anesthetic propofol inhibits multiple human cardiac potassium channels.
Anesthesiology, 2015 Mar , 122 (571-84).

23

Hayashi K et al. Functional Characterization of Rare Variants Implicated in Susceptibility to Lone Atrial Fibrillation.
Circ Arrhythm Electrophysiol, 2015 Jun 30 , ().

24

Warsi J et al. Regulation of Voltage-Gated K(+) Channel Kv1.5 by the Janus Kinase JAK3.
J. Membr. Biol., 2015 Jun 23 , ().

25

Pippucci T et al. Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathy.
EMBO Mol Med, 2015 Jun , 7 (848-58).

26

Yu J et al. Inhibitory effects of cortisone and hydrocortisone on human Kv1.5 channel currents.
Eur. J. Pharmacol., 2015 Jan 5 , 746 (158-66).

27

Ednie AR et al. Reduced sialylation impacts ventricular repolarization by modulating specific K+ channel isoforms distinctly.
J. Biol. Chem., 2015 Jan 30 , 290 (2769-83).

28

Chong E et al. Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activation.
Heart Rhythm, 2015 Jan 30 , ().

29

Chapalamadugu KC et al. High level of oxygen treatment causes cardiotoxicity with arrhythmias and redox modulation.
Toxicol. Appl. Pharmacol., 2015 Jan 1 , 282 (100-7).

30

Zheng L et al. Tanshinone IIA attenuates hypoxic pulmonary hypertension via modulating KV currents.
Respir Physiol Neurobiol, 2015 Jan 1 , 205 (120-8).

31

Devalla HD et al. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.
EMBO Mol Med, 2015 Feb 19 , ().

32

Männikkö R et al. Pharmacological and electrophysiological characterisation of hERG activator AZSMO-23.
Br. J. Pharmacol., 2015 Feb 12 , ().

33

Elvira B et al. SPAK and OSR1 sensitivity of voltage-gated K+ channel Kv1.5.
J. Membr. Biol., 2015 Feb , 248 (59-66).

34

Gasparoli L et al. New pyrimido-indole compound CD-160130 preferentially inhibits the KV11.1B isoform and produces antileukemic effects without cardiotoxicity.
Mol. Pharmacol., 2015 Feb , 87 (183-96).

35

Rudakova E et al. Localization of Kv4.2 and KChIP2 in lipid rafts and modulation of outward K+ currents by membrane cholesterol content in rat left ventricular myocytes.
Pflugers Arch., 2015 Feb , 467 (299-309).

36

Ryland KE et al. Polycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stress.
Oncogene, 2015 Aug 27 , 34 (4591-600).

37

Kidd MW et al. Intravascular pressure enhances the abundance of functional Kv1.5 channels at the surface of arterial smooth muscle cells.
Sci Signal, 2015 Aug 18 , 8 (ra83).

38

Lee JY et al. The role of K⁺ conductances in regulating membrane excitability in human gastric corpus smooth muscle.
Am. J. Physiol. Gastrointest. Liver Physiol., 2015 Apr 1 , 308 (G625-33).

39

Wang J et al. Oral administration of putrescine and proline during the suckling period improves epithelial restitution after early weaning in piglets.
J. Anim. Sci., 2015 Apr , 93 (1679-88).

40

Lang F On the putative purpose of AMPK sensitive Kv1.5 K(+) channel regulation.
Channels (Austin), 2015 , 9 (162).

41

Yamanushi TT et al. Comparison of formaldehyde and methanol fixatives used in the detection of ion channel proteins in isolated rat ventricular myocytes by immunofluorescence labelling and confocal microscopy.
Folia Morphol. (Warsz), 2015 , 74 (258-61).

42

Ou XH et al. Remodeling of Kv1.5 channel in right atria from Han Chinese patients with atrial fibrillation.
Med. Sci. Monit., 2015 , 21 (1207-13).

43

Dai ZK et al. The Xanthine Derivative KMUP-1 Attenuates Serotonin-Induced Vasoconstriction and K⁺-Channel Inhibitory Activity via the PKC Pathway in Pulmonary Arteries.
Int. J. Biol. Sci., 2015 , 11 (633-42).

44

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

45

Singhal R et al. Colchicine suppresses atrial fibrillation in failing heart.
Int. J. Cardiol., 2014 Oct 20 , 176 (651-60).

46

Li B et al. Dichloroacetate prevents but not reverses the formation of neointimal lesions in a rat model of severe pulmonary arterial hypertension.
Mol Med Rep, 2014 Oct , 10 (2144-52).

47

Carrisoza-Gaytán R et al. Differential expression of the Kv1 voltage-gated potassium channel family in the rat nephron.
J. Mol. Histol., 2014 Oct , 45 (583-97).

48

Frolov RV et al. Celecoxib and ion channels: a story of unexpected discoveries.
Eur. J. Pharmacol., 2014 May 5 , 730 (61-71).

49

Fischer F et al. Isoenzyme-specific regulation of cardiac Kv1.5/Kvβ1.2 ion channel complex by protein kinase C: central role of PKCβII.
Naunyn Schmiedebergs Arch. Pharmacol., 2014 May , 387 (469-76).

50

Schumacher-Bass SM et al. Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes.
Circ. Res., 2014 Mar 14 , 114 (982-92).

51

Olsson RI et al. Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channel.
Bioorg. Med. Chem. Lett., 2014 Mar 1 , 24 (1269-73).

52

Guo X et al. Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I).
Eur J Med Chem, 2014 Jun 23 , 81 (89-94).

53

Wu CT et al. Disease and region-related cardiac fibroblast potassium current variations and potential functional significance.
Cardiovasc. Res., 2014 Jun 1 , 102 (487-96).

54

Wang T et al. Muscarinic receptor activation increases hERG channel expression through phosphorylation of ubiquitin ligase Nedd4-2.
Mol. Pharmacol., 2014 Jun , 85 (877-86).

55

Johnson JA et al. Design, synthesis and evaluation of phenethylaminoheterocycles as Kv1.5 inhibitors.
Bioorg. Med. Chem. Lett., 2014 Jul 15 , 24 (3018-22).

56

Luna-Ramírez K et al. Structure, molecular modeling, and function of the novel potassium channel blocker urotoxin isolated from the venom of the Australian scorpion Urodacus yaschenkoi.
Mol. Pharmacol., 2014 Jul , 86 (28-41).

57

Iwata K et al. Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling.
Arterioscler. Thromb. Vasc. Biol., 2014 Jan , 34 (110-9).

58

Wang G et al. Early onset severe pulmonary arterial hypertension with 'two-hit' digenic mutations in both BMPR2 and KCNA5 genes.
Int. J. Cardiol., 2014 Dec 20 , 177 (e167-9).

59

Vu TT et al. Soluble prokaryotic expression and purification of crotamine using an N-terminal maltose-binding protein tag.
Toxicon, 2014 Dec 15 , 92 (157-65).

60

Cidad P et al. K+ channels expression in hypertension after arterial injury, and effect of selective Kv1.3 blockade with PAP-1 on intimal hyperplasia formation.
Cardiovasc Drugs Ther, 2014 Dec , 28 (501-11).

61

Ahmed M et al. Down-regulation of K⁺ channels by human parvovirus B19 capsid protein VP1.
Biochem. Biophys. Res. Commun., 2014 Aug 8 , 450 (1396-401).

62

Schmitt N et al. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.
Physiol. Rev., 2014 Apr , 94 (609-53).

63

Li Z et al. Exercise training reverses alterations in Kv and BKCa channel molecular expression in thoracic aorta smooth muscle cells from spontaneously hypertensive rats.
J. Vasc. Res., 2014 , 51 (447-57).

64

Dun W et al. SAP97 and cortactin remodeling in arrhythmogenic Purkinje cells.
PLoS ONE, 2014 , 9 (e106830).

65

Odagiri F et al. Effects of candesartan on electrical remodeling in the hearts of inherited dilated cardiomyopathy model mice.
PLoS ONE, 2014 , 9 (e101838).

66

Tabarean IV Electrical remodeling of preoptic GABAergic neurons involves the Kv1.5 subunit.
PLoS ONE, 2014 , 9 (e96643).

67

Nielsen JB et al. Gain-of-function mutations in potassium channel subunit KCNE2 associated with early-onset lone atrial fibrillation.
Biomark Med, 2014 , 8 (557-70).

68

Wang J et al. Effect of methamphetamine on the microglial damage: role of potassium channel Kv1.3.
PLoS ONE, 2014 , 9 (e88642).

69

Dong L et al. Potential therapeutic targets for hypoxia-induced pulmonary artery hypertension.
J Transl Med, 2014 , 12 (39).

70

Vonderlin N et al. Inhibition of cardiac Kv1.5 potassium current by the anesthetic midazolam: mode of action.
Drug Des Devel Ther, 2014 , 8 (2263-71).

71

Pousada G et al. Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.
PLoS ONE, 2014 , 9 (e100261).

72

Baczkó I et al. Characterization of a novel multi-functional resveratrol derivative for the treatment of atrial fibrillation.
Br. J. Pharmacol., 2013 Sep 18 , ().

73

Boycott HE et al. Shear stress triggers insertion of voltage-gated potassium channels from intracellular compartments in atrial myocytes.
Proc. Natl. Acad. Sci. U.S.A., 2013 Oct 8 , 110 (E3955-E3964).

74

Olesen MS et al. Very early onset lone atrial fibrillation patients have a high prevalence of rare variants in genes previously associated with atrial fibrillation.
Heart Rhythm, 2013 Oct 18 , ().

75

Vallejo-Gracia A et al. Emerging role for the voltage-dependent K+ channel Kv1.5 in B-lymphocyte physiology: expression associated with human lymphoma malignancy.
J. Leukoc. Biol., 2013 Oct , 94 (779-89).

76

Guo X et al. Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors.
Bioorg. Med. Chem., 2013 Nov 1 , 21 (6466-76).

77

Fedele F et al. Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease.
Basic Res. Cardiol., 2013 Nov , 108 (387).

78

Leanza L et al. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines.
Curr. Pharm. Des., 2013 May 16 , ().

79

Christophersen IE et al. Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation.
Eur. Heart J., 2013 May , 34 (1517-25).

80

Zhang RF et al. [Long term outcome of atrial fibrillation patients with KCNA5 and NPPA mutations post circumferential pulmonary vein ablation].
Zhonghua Xin Xue Guan Bing Za Zhi, 2013 May , 41 (387-9).

81

Finlay HJ et al. Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists.
Bioorg. Med. Chem. Lett., 2013 Mar 15 , 23 (1743-7).

82

Huang H et al. Diet-induced obesity causes long QT and reduces transcription of voltage-gated potassium channels.
J. Mol. Cell. Cardiol., 2013 Jun , 59 (151-8).

83

Cui Z et al. Regulation of the human ether-a-go-go-related gene (hERG) channel by Rab4 protein through neural precursor cell-expressed developmentally down-regulated protein 4-2 (Nedd4-2).
J. Biol. Chem., 2013 Jul 26 , 288 (21876-86).

84

Ravens U et al. Atrial selectivity of antiarrhythmic drugs.
J. Physiol. (Lond.), 2013 Jul 16 , ().

85

Ford J et al. Human Electrophysiological and Pharmacological Properties of XEN-D0101: A Novel Atrial Selective Kv1.5/IKur Inhibitor.
J. Cardiovasc. Pharmacol., 2013 Jan 29 , ().

86

Lang F et al. Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1.
FASEB J., 2013 Jan , 27 (3-12).

87

Fouillade C et al. Transcriptome analysis for Notch3 target genes identifies Grip2 as a novel regulator of myogenic response in the cerebrovasculature.
Arterioscler. Thromb. Vasc. Biol., 2013 Jan , 33 (76-86).

88

Yang Y et al. Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL.
J. Lipid Res., 2013 Jan , 54 (34-43).

89

Olsson RI et al. Synthesis and evaluation of diphenylphosphinic amides and diphenylphosphine oxides as inhibitors of Kv1.5.
Bioorg. Med. Chem. Lett., 2013 Feb 1 , 23 (706-10).

90

Jeong I et al. Pergolide block of the cloned Kv1.5 potassium channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2013 Feb , 386 (125-33).

91

Tikhonov DB et al. Homology modeling of Kv1.5 channel block by cationic and electroneutral ligands.
Biochim. Biophys. Acta, 2013 Dec 5 , 1838 (978-987).

92

Ishii T et al. Sequestosome1/p62: a regulator of redox-sensitive voltage-activated potassium channels, arterial remodeling, inflammation, and neurite outgrowth.
Free Radic. Biol. Med., 2013 Dec , 65 (102-16).

93

Wulff H et al. Channels: Sticking to nooks and crannies.
Nat. Chem. Biol., 2013 Aug , 9 (473-4).

94

Tong M et al. Circadian expressions of cardiac ion channel genes in mouse might be associated with the central clock in the SCN but not the peripheral clock in the heart.
Biol Rhythm Res, 2013 Aug , 44 (519-530).

95

Kim SJ et al. Incretin-stimulated interaction between β-cell Kv1.5 and Kvβ2 channel proteins involves acetylation/deacetylation by CBP/SirT1.
Biochem. J., 2013 Apr 15 , 451 (227-34).

96

Gao M et al. An altered expression of genes involved in the regulation of ion channels in atrial myocytes is correlated with the risk of atrial fibrillation in patients with heart failure.
Exp Ther Med, 2013 Apr , 5 (1239-1243).

97

Mi Y et al. The role of potassium channel activation in celecoxib-induced analgesic action.
PLoS ONE, 2013 , 8 (e54797).

98

Strutz-Seebohm N et al. A Common Structural Component for β-Subunit Mediated Modulation of Slow Inactivation in Different KV Channels.
Cell. Physiol. Biochem., 2013 , 31 (968-80).

99

Zhao N et al. Potent suppression of Kv1.3 potassium channel and IL-2 secretion by diphenyl phosphine oxide-1 in human T cells.
PLoS ONE, 2013 , 8 (e64629).

100

Atkinson AJ et al. Functional, anatomical, and molecular investigation of the cardiac conduction system and arrhythmogenic atrioventricular ring tissue in the rat heart.
J Am Heart Assoc, 2013 , 2 (e000246).

101

Fujii M et al. New screening system for selective blockers of voltage-gated K(+) channels using recombinant cell lines dying upon single action potential.
J. Pharmacol. Sci., 2013 , 123 (147-58).

102

Mia S et al. Downregulation of Kv1.5 K Channels by the AMP-Activated Protein Kinase.
Cell. Physiol. Biochem., 2012 Sep 24 , 30 (1039-1050).

103

Svoboda LK et al. Redox-sensitive sulfenic acid modification regulates surface expression of the cardiovascular voltage-gated potassium channel Kv1.5.
Circ. Res., 2012 Sep 14 , 111 (842-53).

104

Lin CY et al. [Cigarette smoke exposure induced pulmonary artery pressure increase through inhibiting Kv1.5 and Kv2.1 mRNA expression in rat pulmonary artery smooth muscles].
Zhonghua Jie He He Hu Xi Za Zhi, 2012 Sep , 35 (695-9).

105

Barber AF et al. Novel activation of voltage-gated K(+) channels by sevoflurane.
J. Biol. Chem., 2012 Nov 23 , 287 (40425-32).

106

Wang T et al. Trafficking of an endogenous potassium channel in adult ventricular myocytes.
Am. J. Physiol., Cell Physiol., 2012 Nov 1 , 303 (C963-76).

107

Du YM et al. 18β-Glycyrrhetinic acid preferentially blocks late Na current generated by ΔKPQ Nav1.5 channels.
, 2012 May 21 , ().

108

Birner C et al. Differential expression of potassium channels and abnormal conduction in experimental tachycardia-induced heart failure.
Naunyn Schmiedebergs Arch. Pharmacol., 2012 May , 385 (473-80).

109

Kinoshita M et al. Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands.
, 2012 Mar 6 , ().

110

Cidad P et al. Kv1.3 Channels Can Modulate Cell Proliferation During Phenotypic Switch by an Ion-Flux Independent Mechanism.
, 2012 Mar 1 , ().

111

Bielanska J et al. Differential expression of Kv1.3 and Kv1.5 voltage-dependent K+ channels in human skeletal muscle sarcomas.
Cancer Invest., 2012 Mar , 30 (203-8).

112

David M et al. Protein kinase C (PKC) activity regulates functional effects of Kvβ1.3 subunit on KV1.5 channels: identification of a cardiac Kv1.5 channelosome.
J. Biol. Chem., 2012 Jun 15 , 287 (21416-28).

113

Gönczi M et al. Age-dependent changes in ion channel mRNA expression in canine cardiac tissues.
Gen. Physiol. Biophys., 2012 Jun , 31 (153-62).

114

Tipparaju SM et al. Interactions between the C-terminus of Kv1.5 and Kvβ regulate pyridine nucleotide-dependent changes in channel gating.
Pflugers Arch., 2012 Jun , 463 (799-818).

115

Kulzer M et al. Inhibition of cardiac Kir2.1-2.3 channels by beta3 adrenoreceptor antagonist SR 59230A.
Biochem. Biophys. Res. Commun., 2012 Jul 27 , 424 (315-20).

116

Ritchie MD et al. Chromosome 4q25 Variants Are Genetic Modifiers of Rare Ion Channel Mutations Associated With Familial Atrial Fibrillation.
, 2012 Jul 10 , ().

117

Dai F et al. Fluoxetine protects against big endothelin-1 induced anti-apoptosis by rescuing Kv1.5 channels in human pulmonary arterial smooth muscle cells.
Yonsei Med. J., 2012 Jul 1 , 53 (842-8).

118

Kim BS et al. Argonaute2 regulation for K+ channel-mediated human adipose tissue-derived stromal cells self-renewal and survival in nucleus.
Stem Cells Dev., 2012 Jul 1 , 21 (1736-48).

119

Jeong I et al. Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells.
Naunyn Schmiedebergs Arch. Pharmacol., 2012 Jul , 385 (707-16).

120

Munoz C et al. Activation of voltage gated K⁺ channel Kv1.5 by β-catenin.
Biochem. Biophys. Res. Commun., 2012 Jan 13 , 417 (692-6).

121

Li X et al. Extracellular chloride regulation of Kv2.1, contributor to the major outward Kv current in mammalian outer hair cells.
Am. J. Physiol., Cell Physiol., 2012 Jan , 302 (C296-306).

122

Jeong I et al. Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.
Biochem. Pharmacol., 2012 Feb 15 , 83 (497-505).

123

Hald BO et al. BKCa and KV channels limit conducted vasomotor responses in rat mesenteric terminal arterioles.
Pflugers Arch., 2012 Feb , 463 (279-95).

124

Lang F et al. Serum- and glucocorticoid-inducible kinase 1 in the regulation of renal and extrarenal potassium transport.
Clin. Exp. Nephrol., 2012 Feb , 16 (73-80).

125

Suzuki S et al. Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone.
Eur. J. Pharmacol., 2012 Dec 5 , 696 (28-34).

126

Schweikart K et al. The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity.
Toxicol In Vitro, 2012 Dec 20 , 27 (745-751).

127

Ishii K et al. Endocytic regulation of voltage-dependent potassium channels in the heart.
J. Pharmacol. Sci., 2012 Dec 18 , 120 (264-9).

128

Qin M et al. Absence of Rgs5 prolongs cardiac repolarization and predisposes to ventricular tachyarrhythmia in mice.
J. Mol. Cell. Cardiol., 2012 Dec , 53 (880-90).

129

Pavri BB et al. MK-0448, a specific Kv1.5 inhibitor: safety, pharmacokinetics, and pharmacodynamic electrophysiology in experimental animal models and humans.
Circ Arrhythm Electrophysiol, 2012 Dec , 5 (1193-201).

130

Ouyang JS et al. Mitochondrial ROS-K+ channel signaling pathway regulated secretion of human pulmonary artery endothelial cells.
Free Radic. Res., 2012 Dec , 46 (1437-45).

131

Liu Y et al. Effects of the natural flavone trimethylapigenin on cardiac potassium currents.
Biochem. Pharmacol., 2012 Aug 15 , 84 (498-506).

132

Dong Q et al. Hypoxia induces voltage-gated K+ (Kv) channel expression in pulmonary arterial smooth muscle cells through hypoxia-inducible factor-1 (HIF-1).
Bosn J Basic Med Sci, 2012 Aug , 12 (158-63).

133

Asano S et al. Penitrem A as a tool for understanding the role of large conductance Ca(2+)/voltage-sensitive K(+) channels in vascular function.
J. Pharmacol. Exp. Ther., 2012 Aug , 342 (453-60).

134

Suzuki T et al. Multistep ion channel remodeling and lethal arrhythmia precede heart failure in a mouse model of inherited dilated cardiomyopathy.
PLoS ONE, 2012 , 7 (e35353).

135

Yang XF et al. The antibody targeting the e314 Peptide of human kv1.3 pore region serves as a novel, potent and specific channel blocker.
PLoS ONE, 2012 , 7 (e36379).

136

Felipe A et al. Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention.
Curr. Med. Chem., 2012 , 19 (661-74).

137

Moreno C et al. Polyunsaturated Fatty acids modify the gating of kv channels.
Front Pharmacol, 2012 , 3 (163).

138

Xu XH et al. Allitridi inhibits multiple cardiac potassium channels expressed in HEK 293 cells.
PLoS ONE, 2012 , 7 (e51550).

139

Chen WL et al. Involvement of Kv1.5 protein in oxidative vascular endothelial cell injury.
PLoS ONE, 2012 , 7 (e49758).

140

Leanza L et al. Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels.
Curr. Med. Chem., 2012 , 19 (5394-404).

141

Bossini-Castillo L et al. KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor.
Arthritis Res. Ther., 2012 , 14 (R273).

142

Grandi E et al. Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation.
Circ. Res., 2011 Oct 14 , 109 (1055-66).

143

Friederich P et al. The novel Kv1.5 channel blocker vernakalant for successful treatment of new-onset atrial fibrillation in a critically ill abdominal surgical patient.
Br J Anaesth, 2011 Oct , 107 (644-5).

144

Chen C et al. [Effects of puerarin on proliferation, apoptosis and Kv1.5 gene expression of pulmonary artery smooth muscle cells induced by hypoxia].
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 2011 Oct , 29 (731-4).

145

Ferrer T et al. Molecular Coupling in the Human ether-a-go-go-related gene-1 (hERG1) K+ Channel Inactivation Pathway.
J. Biol. Chem., 2011 Nov 11 , 286 (39091-9).

146

Parvez B et al. The "missing" link in atrial fibrillation heritability.
J Electrocardiol, 2011 Nov , 44 (641-4).

147

Whyment AD et al. Electrophysiological, pharmacological and molecular profile of the transient outward rectifying conductance in rat sympathetic preganglionic neurons in vitro.
Neuroscience, 2011 Mar 31 , 178 (68-81).

148

Chen Y et al. The augmenter of liver regeneration protects the kidneys after orthotopic liver transplantation possibly by upregulating HIF-1α and O2-sensitive K+ channels.
Surg. Today, 2011 Mar , 41 (382-9).

149

Arvind S et al. Differential expression of a novel voltage gated potassium channel - Kv1.5 in astrocytomas and its impact on prognosis in glioblastoma.
, 2011 Jun 27 , ().

150

Hu H et al. [Effects of ethanol on action potential of rat myocardium and human Kv1.5 channel].
Sheng Li Xue Bao, 2011 Jun 25 , 63 (219-24).

151

Gurung IS et al. Deletion of the metabolic transcriptional coactivator PGC1{beta} induces cardiac arrhythmia.
, 2011 Jun 1 , ().

152

Mo J et al. Altered gene expression by low-dose arsenic exposure in humans and cultured cardiomyocytes: assessment by real-time PCR arrays.
Int J Environ Res Public Health, 2011 Jun , 8 (2090-108).

153

Goegelein H et al. Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias in rats.
, 2011 Jul 16 , ().

154

Abd Allah E et al. Changes in the expression of ion channels, connexins and Ca2+ handling proteins in the sinoatrial node during postnatal development.
, 2011 Jan 28 , ().

155

Xie J et al. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells.
Int. J. Oncol., 2011 Feb , 38 (409-17).

156

Zhu S et al. Molecular diversity and functional evolution of scorpion potassium channel toxins.
Mol. Cell Proteomics, 2011 Feb , 10 (M110.002832).

157

Wu HJ et al. Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain.
J. Mol. Cell. Cardiol., 2011 Dec , 51 (966-73).

158

Larsen AP et al. Extracellular potassium inhibits Kv7.1 potassium channels by stabilizing an inactivated state.
Biophys. J., 2011 Aug 17 , 101 (818-27).

159

Hu X et al. Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation.
Am. J. Physiol., Cell Physiol., 2011 Aug , 301 (C362-72).

160

Sutendra G et al. Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension.
J. Mol. Med., 2011 Aug , 89 (771-83).

161

Cheng L et al. Cortactin is required for N-cadherin regulation of Kv1.5 channel function.
, 2011 Apr 20 , ().

162

El Gebeily G et al. Upregulation of ventricular potassium channels by chronic tamoxifen treatment.
Cardiovasc. Res., 2011 Apr 1 , 90 (68-76).

163

Mogensen C et al. Isolation and functional characterization of pericytes derived from hamster skeletal muscle.
Acta Physiol (Oxf), 2011 Apr , 201 (413-26).

164

Winkel BG et al. Whole-genome amplified DNA from stored dried blood spots is reliable in high resolution melting curve and sequencing analysis.
BMC Med. Genet., 2011 , 12 (22).

165

Moral-Sanz J et al. Pulmonary arterial dysfunction in insulin resistant obese Zucker rats.
Respir. Res., 2011 , 12 (51).

166

Villalonga N et al. Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels.
Biochem. Pharmacol., 2010 Sep 15 , 80 (858-66).

167

Zhong XZ et al. Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.
J. Physiol. (Lond.), 2010 Sep 1 , 588 (3277-93).

168

Billman GE Vernakalant, a mixed sodium and potassium ion channel antagonist that blocks Kv1.5 channels, for the potential treatment of atrial fibrillation.
Curr Opin Investig Drugs, 2010 Sep , 11 (1048-58).

169

Yang T et al. Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation.
Heart Rhythm, 2010 Sep , 7 (1246-52).

170

Tyan L et al. Inhibition of voltage-gated K+ channels in dendritic cells by rapamycin.
, 2010 Oct 6 , ().

171

Wipff J et al. Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population.
Arthritis Rheum., 2010 Oct , 62 (3093-100).

172

Jeong I et al. Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.
Pflugers Arch., 2010 Oct , 460 (851-62).

173

Almquist J et al. Modeling the effect of kv1.5 block on the canine action potential.
Biophys. J., 2010 Nov 3 , 99 (2726-36).

174

Ravens U et al. Atrial-selective drugs for treatment of atrial fibrillation.
, 2010 Nov 18 , ().

175

Yang T et al. Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1.
Br. J. Pharmacol., 2010 Nov , 161 (1023-33).

176

Dai ZK et al. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
Life Sci., 2010 May 8 , 86 (747-55).

177

Chen P et al. Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxins.
J. Biol. Chem., 2010 May 14 , 285 (14882-9).

178

Dumas de la Roque E et al. Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension.
Pharmacol. Ther., 2010 May , 126 (186-99).

179

Jonsson MK et al. Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes.
Stem Cell Res, 2010 May , 4 (189-200).

180

Dou Y et al. Normal targeting of a tagged Kv1.5 channel acutely transfected into fresh adult cardiac myocytes by a biolistic method.
, 2010 Mar 31 , ().

181

Hansen HS Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.
, 2010 Mar 27 , ().

182

Rangaraju S et al. Potassium channel modulation by a toxin domain in matrix metalloprotease 23.
J. Biol. Chem., 2010 Mar 19 , 285 (9124-36).

183

Akhavan A Motorized traffic of a cardiac ion channel: implication of conventional kinesin in transport of Kv1.5 channels to the plasma membrane.
J. Physiol. (Lond.), 2010 Mar 15 , 588 (903-4).

184

James SR et al. The effects of acute triiodothyronine therapy on myocardial gene expression in brain stem dead cardiac donors.
J. Clin. Endocrinol. Metab., 2010 Mar , 95 (1338-43).

185

Burg ED et al. Tetramerization domain mutations in KCNA5 affect channel kinetics and cause abnormal trafficking patterns.
Am. J. Physiol., Cell Physiol., 2010 Mar , 298 (C496-509).

186

Cheng YM et al. Kinetic analysis of the effects of H+ or Ni2+ on Kv1.5 current shows that both ions enhance slow inactivation and induce resting inactivation.
, 2010 Jun 25 , ().

187

Liu J et al. [Expression and properties of potassium channels in human mammary epithelial cell line MCF10A and its possible role in proliferation].
Sheng Li Xue Bao, 2010 Jun 25 , 62 (203-9).

188

Amenta JJ et al. The glitter of gold: biolistic transfection of fresh adult cardiac myocytes. Focus on "normal targeting of a tagged Kv1.5 channel acutely transfected into fresh adult cardiac myocytes by a biolistic method".
Am. J. Physiol., Cell Physiol., 2010 Jun , 298 (C1305-7).

189

Gonzalez T et al. Kv1.5-Kv beta interactions: molecular determinants and pharmacological consequences.
Mini Rev Med Chem, 2010 Jun , 10 (635-42).

190

Horne AJ et al. Fast and slow voltage sensor rearrangements during activation gating in Kv1.2 channels detected using tetramethylrhodamine fluorescence.
J. Gen. Physiol., 2010 Jul , 136 (83-99).

191

Barana A et al. Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.
Cardiovasc. Res., 2010 Jan 1 , 85 (56-67).

192

Koeberle PD et al. Kv1.1 and Kv1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo.
Cell Death Differ., 2010 Jan , 17 (134-44).

193

Tanaka H et al. Effect of NIP-142 on potassium channel alpha-subunits Kv1.5, Kv4.2 and Kv4.3, and mouse atrial repolarization.
Biol. Pharm. Bull., 2010 Jan , 33 (138-41).

194

Moreno-Galindo EG et al. Molecular Basis for a High-Potency Open Channel Block of Kv1.5 Channel by the Endocannabinoid Anandamide.
, 2010 Feb 4 , ().

195

Du YM et al. Molecular determinants of Kv1.5 Channel block by diphenyl phosphine oxide-1.
, 2010 Feb 22 , ().

196

Lloyd J et al. Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockers.
Bioorg. Med. Chem. Lett., 2010 Feb 15 , 20 (1436-9).

197

Schumacher SM et al. Ion Channel Trafficking: A New Therapeutic Horizon for Atrial Fibrillation.
, 2010 Feb 12 , ().

198

Haim TE et al. Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents.
J. Mol. Cell. Cardiol., 2010 Feb , 48 (395-405).

199

Ravens U et al. Ultra-rapid delayed rectifier channels - molecular basis and therapeutic implications.
, 2010 Dec 15 , ().

200

Oh S et al. Remodeling of ion channel expression in patients with chronic atrial fibrillation and mitral valvular heart disease.
Korean J. Intern. Med., 2010 Dec , 25 (377-85).

201

Macías A et al. Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials.
J. Mol. Cell. Cardiol., 2010 Dec , 49 (984-92).

202

Li Y et al. Aconitine blocks HERG and Kv1.5 potassium channels.
, 2010 Aug 19 , 131 (187-195).

203

Large R et al. Ionic Currents in Intimal Cultured Synoviocytes from the Rabbit.
, 2010 Aug 18 , ().

204

Gao B et al. A potent potassium channel blocker from Mesobuthus eupeus scorpion venom.
, 2010 Aug 13 , ().

205

Gater D 32nd national medicinal chemistry symposium - medicinal chemistry developments for neurodegeneration, diabetes and cancer.
IDrugs, 2010 Aug , 13 (514-6).

206

Gater D 32nd National Medicinal Chemistry Symposium--medicinal chemistry developments for cancer, and cardiovascular, metabolic and psychiatric disorders.
IDrugs, 2010 Aug , 13 (517-9).

207

Yang YQ et al. [Identification and functional analysis of a KCNA5 mutation responsible for idiopathic atrial fibrillation]
Zhonghua Yi Xue Za Zhi, 2010 Apr 27 , 90 (1100-4).

208

Beshore DC et al. Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel.
Bioorg. Med. Chem. Lett., 2010 Apr 15 , 20 (2493-6).

209

Lee HM et al. Open channel block of Kv1.5 currents by citalopram.
Acta Pharmacol. Sin., 2010 Apr , 31 (429-35).

210

Park WS et al. Patho-, physiological roles of voltage-dependent K+ channels in pulmonary arterial smooth muscle cells.
J Smooth Muscle Res, 2010 , 46 (89-105).

211

Bielanska J et al. Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus.
Cell. Physiol. Biochem., 2010 , 26 (219-26).

212

Lee HM et al. Inhibitory action of fluvoxamine on Kv1.5 currents.
Biol. Pharm. Bull., 2010 , 33 (977-82).

213

Antzelevitch C et al. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
J Electrocardiol, 2009 Nov-Dec , 42 (543-8).

214

Vaid M et al. Rapid outer pore movements after opening in a KV1 potassium channel are revealed by TMRM fluorescence from the S3-S4 linker, and modulated by extracellular potassium.
Channels (Austin), 2009 Jan-Feb , 3 (3-5).

215

Bonnet S et al. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis.
Circulation, 2009 Sep 29 , 120 (1231-40).

216

Papp F et al. Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus.
Toxicon, 2009 Sep 15 , 54 (379-89).

217

Zadeh AD et al. Kif5b is an essential forward trafficking motor for the Kv1.5 cardiac potassium channel.
J. Physiol. (Lond.), 2009 Oct 1 , 587 (4565-74).

218

Eldstrom J et al. Modeling of high-affinity binding of the novel atrial anti-arrhythmic agent, vernakalant, to Kv1.5 channels.
J. Mol. Graph. Model., 2009 Oct , 28 (226-35).

219

Cai D et al. Single molecule imaging reveals differences in microtubule track selection between Kinesin motors.
PLoS Biol., 2009 Oct , 7 (e1000216).

220

Firth AL et al. Hypoxia selectively inhibits KCNA5 channels in pulmonary artery smooth muscle cells.
Ann. N. Y. Acad. Sci., 2009 Oct , 1177 (101-11).

221

Blass BE et al. Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia.
J. Med. Chem., 2009 Nov 12 , 52 (6531-4).

222

Yang Y et al. Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation.
J. Hum. Genet., 2009 May , 54 (277-83).

223

Chen J et al. PKA phosphorylation of HERG protein regulates the rate of channel synthesis.
Am. J. Physiol. Heart Circ. Physiol., 2009 May , 296 (H1244-54).

224

Ureche ON et al. Differential modulation of cardiac potassium channels by Grb adaptor proteins.
Biochem. Biophys. Res. Commun., 2009 Jun 19 , 384 (28-31).

225

Schumacher SM et al. Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
Circ. Res., 2009 Jun 19 , 104 (1390-8).

226

Gross MF et al. Aryl sulfonamido tetralin inhibitors of the Kv1.5 ion channel.
Bioorg. Med. Chem. Lett., 2009 Jun 1 , 19 (3063-6).

227

Sridhar A et al. Chronic heart failure and the substrate for atrial fibrillation.
Cardiovasc. Res., 2009 Jul 17 , ().

228

Zhu J et al. The Kv1.2 potassium channel: the position of an N-glycan on the extracellular linkers affects its protein expression and function.
Brain Res., 2009 Jan 28 , 1251 (16-29).

229

Karczewski J et al. High-throughput analysis of drug binding interactions for the human cardiac channel, Kv1.5.
Biochem. Pharmacol., 2009 Jan 15 , 77 (177-85).

230

Chu X et al. Hypoxia suppresses KV1.5 channel expression through endogenous 15-HETE in rat pulmonary artery.
Prostaglandins Other Lipid Mediat., 2009 Jan , 88 (42-50).

231

Wu J et al. Inhibitory actions of the phosphatidylinositol 3-kinase inhibitor LY294002 on the human Kv1.5 channel.
Br. J. Pharmacol., 2009 Jan , 156 (377-87).

232

Koshida S et al. Stabilizing effects of eicosapentaenoic acid on Kv1.5 channel protein expressed in mammalian cells.
Eur. J. Pharmacol., 2009 Feb 14 , 604 (93-102).

233

Hyvelin JM et al. Adaptative modifications of right coronary myocytes voltage-gated K+ currents in rat with hypoxic pulmonary hypertension.
Pflugers Arch., 2009 Feb , 457 (721-30).

234

Yang L et al. Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment.
Clin. Exp. Pharmacol. Physiol., 2009 Feb , 36 (154-61).

235

Li MW et al. [Effects of telmisartan on voltage-gated Kv1.3 and Kv1.5 potassium channels expressed in Xenopus oocytes]
Zhonghua Xin Xue Guan Bing Za Zhi, 2009 Feb , 37 (165-8).

236

Lee SM et al. Down-regulation of delayed rectifier K+ channels in the hippocampus of seizure sensitive gerbils.
Brain Res. Bull., 2009 Dec 16 , 80 (433-42).

237

Guignabert C et al. Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporter.
FASEB J., 2009 Dec , 23 (4135-47).

238

Bielanska J et al. Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer.
Curr Cancer Drug Targets, 2009 Dec , 9 (904-14).

239

Balse E et al. Cholesterol modulates the recruitment of Kv1.5 channels from Rab11-associated recycling endosome in native atrial myocytes.
Proc. Natl. Acad. Sci. U.S.A., 2009 Aug 25 , 106 (14681-6).

240

Saito T et al. Estrogen contributes to gender differences in mouse ventricular repolarization.
Circ. Res., 2009 Aug 14 , 105 (343-52).

241

Zhai FG et al. Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats.
Clin. Exp. Pharmacol. Physiol., 2009 Aug , 36 (850-6).

242

Kang LS et al. Aging and muscle fiber type alter K+ channel contributions to the myogenic response in skeletal muscle arterioles.
J. Appl. Physiol., 2009 Aug , 107 (389-98).

243

Wang Z et al. Control of voltage-gated K+ channel permeability to NMDG+ by a residue at the outer pore.
J. Gen. Physiol., 2009 Apr , 133 (361-74).

244

Tamargo J et al. I(Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillation.
, 2009 Apr , 18 (399-416).

245

Laufer J et al. The C-terminal PDZ-binding motif in the Kv1.5 potassium channel governs its modulation by the Na+/H+ exchanger regulatory factor 2.
Cell. Physiol. Biochem., 2009 , 23 (25-36).

246

Yang Q et al. Drug discoveries towards Kv1.5 potassium channel.
, 2009 , 9 (339-47).

247

Bilodeau MT et al. Kv1.5 blockers for the treatment of atrial fibrillation: approaches to optimization of potency and selectivity and translation to in vivo pharmacology.
Curr Top Med Chem, 2009 , 9 (436-51).

248

Cutz E et al. The role of NOX2 and "novel oxidases" in airway chemoreceptor O(2) sensing.
Adv. Exp. Med. Biol., 2009 , 648 (427-38).

249

Xuan NT et al. Ca2+-dependent functions in peptidoglycan-stimulated mouse dendritic cells.
Cell. Physiol. Biochem., 2009 , 24 (167-76).

250

Li GR et al. Characterization of multiple ion channels in cultured human cardiac fibroblasts.
PLoS ONE, 2009 , 4 (e7307).

251

Zhou P et al. Testosterone deprivation by castration impairs expression of voltage-dependent potassium channels in rat aorta.
Eur. J. Pharmacol., 2008 Sep 28 , 593 (87-91).

252

Yang Q et al. Modeling the binding modes of Kv1.5 potassium channel and blockers.
J. Mol. Graph. Model., 2008 Sep , 27 (178-87).

253

Lvov A et al. VAMP2 interacts directly with the N terminus of Kv2.1 to enhance channel inactivation.
Pflugers Arch., 2008 Sep , 456 (1121-36).

254

Burashnikov A et al. Can inhibition of IKur promote atrial fibrillation?
, 2008 Sep , 5 (1304-9).

255

Aréchiga IA et al. Kv1.5 open channel block by the antiarrhythmic drug disopyramide: molecular determinants of block.
J. Pharmacol. Sci., 2008 Sep , 108 (49-55).

256

Zadeh AD et al. Internalized Kv1.5 traffics via Rab-dependent pathways.
J. Physiol. (Lond.), 2008 Oct 15 , 586 (4793-813).

257

Buniel M et al. Distribution of voltage-gated potassium and hyperpolarization-activated channels in sensory afferent fibers in the rat carotid body.
J. Comp. Neurol., 2008 Oct 1 , 510 (367-77).

258

Roepke TK et al. Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f).
FASEB J., 2008 Oct , 22 (3648-60).

259

Matzner N et al. Ion channels modulating mouse dendritic cell functions.
J. Immunol., 2008 Nov 15 , 181 (6803-9).

260

Cheng YM et al. External Ba2+ block of human Kv1.5 at neutral and acidic pH: evidence for Ho+-induced constriction of the outer pore mouth at rest.
Biophys. J., 2008 Nov 1 , 95 (4456-68).

261

Villalonga N et al. Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation.
Biochim. Biophys. Acta, 2008 May , 1783 (728-36).

262

Jindal HK et al. Posttranslational modification of voltage-dependent potassium channel Kv1.5: COOH-terminal palmitoylation modulates its biological properties.
Am. J. Physiol. Heart Circ. Physiol., 2008 May , 294 (H2012-21).

263

Johnson JN et al. Prevalence of early-onset atrial fibrillation in congenital long QT syndrome.
Heart Rhythm, 2008 May , 5 (704-9).

264

Vicente R et al. Kv1.5 association modifies Kv1.3 traffic and membrane localization.
J. Biol. Chem., 2008 Mar 28 , 283 (8756-64).

265

McEwen DP et al. Caveolin regulates kv1.5 trafficking to cholesterol-rich membrane microdomains.
Mol. Pharmacol., 2008 Mar , 73 (678-85).

266

Wang X et al. [Optimization of method for detecting the activation of potassium channels in rat cardiac muscle cells]
Sheng Wu Gong Cheng Xue Bao, 2008 Mar , 24 (521-4).

267

Marionneau C et al. Distinct cellular and molecular mechanisms underlie functional remodeling of repolarizing K+ currents with left ventricular hypertrophy.
Circ. Res., 2008 Jun 6 , 102 (1406-15).

268

Dobrev D et al. Four and a half LIM protein 1: a novel chaperone for atrium-specific Kv1.5 channels with a potential role in atrial arrhythmogenesis.
Cardiovasc. Res., 2008 Jun 1 , 78 (411-2).

269

Yang Z et al. Four and a half LIM protein 1: a partner for KCNA5 in human atrium.
Cardiovasc. Res., 2008 Jun 1 , 78 (449-57).

270

Liu GX et al. Single-channel properties of I K,slow1 and I K,slow2 in mouse ventricular myocytes.
Pflugers Arch., 2008 Jun , 456 (541-7).

271

Labro AJ et al. A Kv channel with an altered activation gate sequence displays both "fast" and "slow" activation kinetics.
Am. J. Physiol., Cell Physiol., 2008 Jun , 294 (C1476-84).

272

Wong JY et al. Dichloroacetate induces apoptosis in endometrial cancer cells.
Gynecol. Oncol., 2008 Jun , 109 (394-402).

273

Regan CP et al. Atrial antifibrillatory effects of structurally distinct IKur blockers 3-[(dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in dogs with underlying heart failure.
J. Pharmacol. Exp. Ther., 2008 Jan , 324 (322-30).

274

Plante I et al. A pilot study to estimate the feasibility of assessing the relationships between polymorphisms in hKv1.5 and atrial fibrillation in patients following coronary artery bypass graft surgery.
, 2008 Jan , 24 (41-4).

275

Salom JB et al. Role of K+ and Ca2+ fluxes in the cerebroarterial vasoactive effects of sildenafil.
Eur. J. Pharmacol., 2008 Feb 26 , 581 (138-47).

276

Andér M et al. Ligand binding to the voltage-gated Kv1.5 potassium channel in the open state--docking and computer simulations of a homology model.
Biophys. J., 2008 Feb 1 , 94 (820-31).

277

Zahn RK et al. Reduced ictogenic potential of 4-aminopyridine in the perirhinal and entorhinal cortex of kainate-treated chronic epileptic rats.
Neurobiol. Dis., 2008 Feb , 29 (186-200).

278

Archer SL et al. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.
Am. J. Physiol. Heart Circ. Physiol., 2008 Feb , 294 (H570-8).

279

Guizy M et al. Modulation of the atrial specific Kv1.5 channel by the n-3 polyunsaturated fatty acid, alpha-linolenic acid.
J. Mol. Cell. Cardiol., 2008 Feb , 44 (323-35).

280

Walsh KB et al. Neonatal rat cardiac fibroblasts express three types of voltage-gated K+ channels: regulation of a transient outward current by protein kinase C.
Am. J. Physiol. Heart Circ. Physiol., 2008 Feb , 294 (H1010-7).

281

Cox RH et al. Voltage gated K+ channel expression in arteries of Wistar-Kyoto and spontaneously hypertensive rats.
Am. J. Hypertens., 2008 Feb , 21 (213-8).

282

Decher N et al. Structural determinants of Kvbeta1.3-induced channel inactivation: a hairpin modulated by PIP2.
EMBO J., 2008 Dec 3 , 27 (3164-74).

283

Gong YZ et al. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
Eur. J. Pharmacol., 2008 Dec 14 , 600 (18-25).

284

Martínez-Mármol R et al. Multiple Kv1.5 targeting to membrane surface microdomains.
J. Cell. Physiol., 2008 Dec , 217 (667-73).

285

Labro AJ et al. Kv channel gating requires a compatible S4-S5 linker and bottom part of S6, constrained by non-interacting residues.
J. Gen. Physiol., 2008 Dec , 132 (667-80).

286

Noguchi C et al. Inhibitory effects of isoliquiritigenin and licorice extract on voltage-dependent K(+) currents in H9c2 cells.
J. Pharmacol. Sci., 2008 Dec , 108 (439-45).

287

Cui JX et al. [Study on the roles of voltaged potassium channels in acute hypoxic pulmonary vasoconstriction]
Nan Fang Yi Ke Da Xue Xue Bao, 2008 Dec , 28 (2200-1).

288

Sun DD et al. Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels.
Eur. J. Pharmacol., 2008 Aug 20 , 590 (317-21).

289

Hirota Y et al. Functional stabilization of Kv1.5 protein by Hsp70 in mammalian cell lines.
Biochem. Biophys. Res. Commun., 2008 Aug 1 , 372 (469-74).

290

Lu Z et al. Reactive oxygen species-induced activation of p90 ribosomal S6 kinase prolongs cardiac repolarization through inhibiting outward K+ channel activity.
Circ. Res., 2008 Aug 1 , 103 (269-78).

291

Vaid M et al. Voltage clamp fluorimetry reveals a novel outer pore instability in a mammalian voltage-gated potassium channel.
J. Gen. Physiol., 2008 Aug , 132 (209-22).

292

Tu DN et al. Electropharmacological properties of telmisartan in blocking hKv1.5 and HERG potassium channels expressed on Xenopus laevis oocytes.
Acta Pharmacol. Sin., 2008 Aug , 29 (913-22).

293

Ford JW et al. New drugs targeting the cardiac ultra-rapid delayed-rectifier current (I Kur): rationale, pharmacology and evidence for potential therapeutic value.
J. Cardiovasc. Pharmacol., 2008 Aug , 52 (105-20).

294

Yeung CH et al. Potassium channels involved in human sperm volume regulation--quantitative studies at the protein and mRNA levels.
Mol. Reprod. Dev., 2008 Apr , 75 (659-68).

295

Abi-Char J et al. The anchoring protein SAP97 retains Kv1.5 channels in the plasma membrane of cardiac myocytes.
Am. J. Physiol. Heart Circ. Physiol., 2008 Apr , 294 (H1851-61).

296

Ehrlich JR et al. Characterization of human cardiac Kv1.5 inhibition by the novel atrial-selective antiarrhythmic compound AVE1231.
J. Cardiovasc. Pharmacol., 2008 Apr , 51 (380-7).

297

Boehmer C et al. Modulation of the voltage-gated potassium channel Kv1.5 by the SGK1 protein kinase involves inhibition of channel ubiquitination.
Cell. Physiol. Biochem., 2008 , 22 (591-600).

298

Li HY et al. Eugenol inhibits K+ currents in trigeminal ganglion neurons.
J. Dent. Res., 2007 Sep , 86 (898-902).

299

McEwen DP et al. Rab-GTPase-dependent endocytic recycling of Kv1.5 in atrial myocytes.
J. Biol. Chem., 2007 Oct 5 , 282 (29612-20).

300

Arias C et al. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
Anesthesiology, 2007 Oct , 107 (641-51).

301

Koutsouki E et al. Modulation of human Kv1.5 channel kinetics by N-cadherin.
Biochem. Biophys. Res. Commun., 2007 Nov 9 , 363 (18-23).

302

Fountain SJ et al. K(v)1.5 potassium channel gene regulation by Sp1 transcription factor and oxidative stress.
Am. J. Physiol. Heart Circ. Physiol., 2007 Nov , 293 (H2719-25).

303

Bai X et al. Electrophysiological properties of human adipose tissue-derived stem cells.
Am. J. Physiol., Cell Physiol., 2007 Nov , 293 (C1539-50).

304

Wettwer E Is there a functional correlate of Kv1.5 in the ventricle of canine heart and what would it mean for the use of I(Kur) blockers?
Br. J. Pharmacol., 2007 Nov , 152 (835-7).

305

Sridhar A et al. The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization.
Br. J. Pharmacol., 2007 Nov , 152 (870-9).

306

Gross MF et al. Aryl sulfonamido indane inhibitors of the Kv1.5 ion channel.
Bioorg. Med. Chem. Lett., 2007 May 15 , 17 (2849-53).

307

Remillard CV et al. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
Am. J. Physiol., Cell Physiol., 2007 May , 292 (C1837-53).

308

Vaquero M et al. Effects of atorvastatin and simvastatin on atrial plateau currents.
J. Mol. Cell. Cardiol., 2007 May , 42 (931-45).

309

Martínez-Gómez A et al. Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve.
Neuroreport, 2007 Mar 26 , 18 (447-50).

310

Nielsen NH et al. Mutations in the Kv1.5 channel gene KCNA5 in cardiac arrest patients.
Biochem. Biophys. Res. Commun., 2007 Mar 16 , 354 (776-82).

311

Eduljee C et al. SCAM analysis reveals a discrete region of the pore turret that modulates slow inactivation in Kv1.5.
Am. J. Physiol., Cell Physiol., 2007 Mar , 292 (C1041-52).

312

Kim DS et al. Seizure activity affects neuroglial Kv1 channel immunoreactivities in the gerbil hippocampus.
Brain Res., 2007 Jun 2 , 1151 (172-87).

313

Lloyd J et al. Benzopyran sulfonamides as KV1.5 potassium channel blockers.
Bioorg. Med. Chem. Lett., 2007 Jun 15 , 17 (3271-5).

314

Bonnet S et al. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
Proc. Natl. Acad. Sci. U.S.A., 2007 Jul 3 , 104 (11418-23).

315

Tipparaju SM et al. NADPH binding to beta-subunit regulates inactivation of voltage-gated K(+) channels.
Biochem. Biophys. Res. Commun., 2007 Jul 27 , 359 (269-76).

316

Gaborit N et al. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart.
J. Physiol. (Lond.), 2007 Jul 15 , 582 (675-93).

317

Zhang L et al. S-acylation regulates Kv1.5 channel surface expression.
Am. J. Physiol., Cell Physiol., 2007 Jul , 293 (C152-61).

318

Han Y et al. Detection of potassium currents and regulation of multidrug resistance by potassium channels in human gastric cancer cells.
Cell Biol. Int., 2007 Jul , 31 (741-7).

319

Ehrlich JR et al. Novel anti-arrhythmic drugs for atrial fibrillation management.
, 2007 Jul , 5 (185-95).

320

Villalonga N et al. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages.
Biochem. Biophys. Res. Commun., 2007 Jan 26 , 352 (913-8).

321

Jackson CM et al. Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias.
Bioorg. Med. Chem. Lett., 2007 Jan 1 , 17 (282-4).

322

Gautier M et al. Heterogeneous Kv1 function and expression in coronary myocytes from right and left ventricles in rats.
Am. J. Physiol. Heart Circ. Physiol., 2007 Jan , 292 (H475-82).

323

Bonnet S et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.
Cancer Cell, 2007 Jan , 11 (37-51).

324

Wu C et al. Developmental changes in the expression of voltage-gated potassium channels in the ductus arteriosus of the fetal rat.
, 2007 Jan , 22 (34-40).

325

Benson MD et al. SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5.
Proc. Natl. Acad. Sci. U.S.A., 2007 Feb 6 , 104 (1805-10).

326

Ousingsawat J et al. Expression of voltage-gated potassium channels in human and mouse colonic carcinoma.
Clin. Cancer Res., 2007 Feb 1 , 13 (824-31).

327

McGahon MK et al. Kv1.5 is a major component underlying the A-type potassium current in retinal arteriolar smooth muscle.
Am. J. Physiol. Heart Circ. Physiol., 2007 Feb , 292 (H1001-8).

328

Eun JS et al. Synthesis of psoralen derivatives and their blocking effect of hKv1.5 channel.
Arch. Pharm. Res., 2007 Feb , 30 (155-60).

329

Tang Q et al. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells.
Biochem. Pharmacol., 2007 Dec 3 , 74 (1596-607).

330

Rezazadeh S et al. An activation gating switch in Kv1.2 is localized to a threonine residue in the S2-S3 linker.
Biophys. J., 2007 Dec 15 , 93 (4173-86).

331

Eldstrom J et al. The molecular basis of high-affinity binding of the antiarrhythmic compound vernakalant (RSD1235) to Kv1.5 channels.
Mol. Pharmacol., 2007 Dec , 72 (1522-34).

332

Chai Q et al. Molecular basis of dysfunctional Kv channels in small coronary artery smooth muscle cells of streptozotocin-induced diabetic rats.
, 2007 Aug 31 , 50 (171-7).

333

Abi-Char J et al. Membrane cholesterol modulates Kv1.5 potassium channel distribution and function in rat cardiomyocytes.
J. Physiol. (Lond.), 2007 Aug 1 , 582 (1205-17).

334

Platoshyn O et al. Heterogeneity of hypoxia-mediated decrease in I(K(V)) and increase in [Ca2+](cyt) in pulmonary artery smooth muscle cells.
Am. J. Physiol. Lung Cell Mol. Physiol., 2007 Aug , 293 (L402-16).

335

Wirth KJ et al. In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.
J. Cardiovasc. Pharmacol., 2007 Apr , 49 (197-206).

336

Strutz-Seebohm N et al. Comparison of potent Kv1.5 potassium channel inhibitors reveals the molecular basis for blocking kinetics and binding mode.
Cell. Physiol. Biochem., 2007 , 20 (791-800).

337

Cooper TG et al. Involvement of potassium and chloride channels and other transporters in volume regulation by spermatozoa.
Curr. Pharm. Des., 2007 , 13 (3222-30).

338

Blass BE et al. Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillation.
Bioorg. Med. Chem. Lett., 2006 Sep 1 , 16 (4629-32).

339

Núñez L et al. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism.
Cardiovasc. Res., 2006 Oct 1 , 72 (80-9).

340

Decher N et al. Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation.
Mol. Pharmacol., 2006 Oct , 70 (1204-11).

341

Kwak YG et al. Torilin from Torilis japonica (Houtt.) DC. blocks hKv1.5 channel current.
Arch. Pharm. Res., 2006 Oct , 29 (834-9).

342

Trotter BW et al. Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation.
J. Med. Chem., 2006 Nov 30 , 49 (6954-7).

343

Wu S et al. Discovery and synthesis of tetrahydroindolone derived semicarbazones as selective Kv1.5 blockers.
Bioorg. Med. Chem. Lett., 2006 Nov 15 , 16 (5859-63).

344

Fluxe A et al. Discovery and synthesis of tetrahydroindolone-derived carbamates as Kv1.5 blockers.
Bioorg. Med. Chem. Lett., 2006 Nov 15 , 16 (5855-8).

345

Nanda KK et al. Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamides.
Bioorg. Med. Chem. Lett., 2006 Nov 15 , 16 (5897-901).

346

Eldstrom J et al. Localization of Kv1.5 channels in rat and canine myocyte sarcolemma.
FEBS Lett., 2006 Nov 13 , 580 (6039-46).

347

Abdel-Mottaleb Y et al. The first potassium channel toxin from the venom of the Iranian scorpion Odonthobuthus doriae.
FEBS Lett., 2006 Nov 13 , 580 (6254-8).

348

Fantozzi I et al. Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells.
Am. J. Physiol. Lung Cell Mol. Physiol., 2006 Nov , 291 (L993-1004).

349

Salvador-Recatalà V et al. Voltage-gated k+ channel block by catechol derivatives: defining nonselective and selective pharmacophores.
J. Pharmacol. Exp. Ther., 2006 Nov , 319 (758-64).

350

Ehrlich JR et al. Properties of a time-dependent potassium current in pig atrium: evidence for a role of kv1.5 in repolarization.
J. Pharmacol. Exp. Ther., 2006 Nov , 319 (898-906).

351

Iwasaki YK et al. A method for the simultaneous analysis of mRNA levels of multiple cardiac ion channels with a multi-probe RNase protection assay.
, 2006 Nov , 8 (1011-5).

352

Mathur R et al. A specific N-terminal residue in Kv1.5 is required for upregulation of the channel by SAP97.
Biochem. Biophys. Res. Commun., 2006 Mar 31 , 342 (1-8).

353

Maguy A et al. Involvement of lipid rafts and caveolae in cardiac ion channel function.
Cardiovasc. Res., 2006 Mar 1 , 69 (798-807).

354

Platoshyn O et al. Acute hypoxia selectively inhibits KCNA5 channels in pulmonary artery smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2006 Mar , 290 (C907-16).

355

Bonnet S et al. An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.
Circulation, 2006 Jun 6 , 113 (2630-41).

356

Plante I et al. Electrophysiological characterization of three non-synonymous single nucleotide polymorphisms (R87Q, A251T, and P307S) found in hKv1.5.
Pflugers Arch., 2006 Jun , 452 (316-23).

357

Lagrutta A et al. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
J. Pharmacol. Exp. Ther., 2006 Jun , 317 (1054-63).

358

Tanabe Y et al. Over-expression of Kv1.5 in rat cardiomyocytes extremely shortens the duration of the action potential and causes rapid excitation.
Biochem. Biophys. Res. Commun., 2006 Jul 7 , 345 (1116-21).

359

Chen TT et al. Key role of Kv1 channels in vasoregulation.
Circ. Res., 2006 Jul 7 , 99 (53-60).

360

Park SA et al. hKv1.5 channels play a pivotal role in the functions of human alveolar macrophages.
Biochem. Biophys. Res. Commun., 2006 Jul 28 , 346 (567-71).

361

Olson TM et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation.
Hum. Mol. Genet., 2006 Jul 15 , 15 (2185-91).

362

Mullen KM et al. Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system.
Ann. Neurol., 2006 Jul , 60 (118-27).

363

Kwan DC et al. Single channel analysis reveals different modes of Kv1.5 gating behavior regulated by changes of external pH.
Biophys. J., 2006 Feb 15 , 90 (1212-22).

364

Regan CP et al. In vivo cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker, (2-Isopropyl-5-methylcyclohexyl) diphenylphosphine oxide, in rat and nonhuman primate.
J. Pharmacol. Exp. Ther., 2006 Feb , 316 (727-32).

365

Hayama E et al. Analysis of voltage-gated potassium channel beta1 subunits in the porcine neonatal ductus arteriosus.
Pediatr. Res., 2006 Feb , 59 (167-74).

366

Vicente R et al. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages.
J. Biol. Chem., 2006 Dec 8 , 281 (37675-85).

367

Wu S et al. Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockers.
Bioorg. Med. Chem. Lett., 2006 Dec 15 , 16 (6213-8).

368

Claydon TW et al. Block by internal Mg2+ causes voltage-dependent inactivation of Kv1.5.
Eur. Biophys. J., 2006 Dec , 36 (23-34).

369

Pannasch U et al. The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microglia.
Mol. Cell. Neurosci., 2006 Dec , 33 (401-11).

370

Moudgil R et al. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
, 2006 Dec , 13 (615-32).

371

Balana B et al. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells.
Cell Res., 2006 Dec , 16 (949-60).

372

Ordög B et al. Gene expression profiling of human cardiac potassium and sodium channels.
Int. J. Cardiol., 2006 Aug 28 , 111 (386-93).

373

Zhou C et al. Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA.
Circ. Res., 2006 Apr 28 , 98 (1040-7).

374

Cogolludo A et al. Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization.
Circ. Res., 2006 Apr 14 , 98 (931-8).

375

Rezazadeh S et al. KN-93 (2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a calcium/calmodulin-dependent protein kinase II inhibitor, is a direct extracellular blocker of voltage-gated potassium channels.
J. Pharmacol. Exp. Ther., 2006 Apr , 317 (292-9).

376

Ye H et al. [Effect of exercise stress on cigarette smoking induced downregulation of BKca and Kv1.5 expression in pulmonary arterial smooth muscle cells of rats]
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 2006 Apr , 24 (218-21).

377

Zhang HX et al. [mRNA expression of voltage-dependent potassium channels in the brain of rats after middle cerebral artery occlusion]
Yao Xue Xue Bao, 2006 Apr , 41 (328-32).

378

Bundis F et al. Involvement of Golgin-160 in cell surface transport of renal ROMK channel: co-expression of Golgin-160 increases ROMK currents.
Cell. Physiol. Biochem., 2006 , 17 (1-12).

379

Pirard B et al. The discovery of Kv1.5 blockers as a case study for the application of virtual screening approaches.
, 2005 Mar-Apr , 45 (477-85).

380

Hong Z et al. Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction.
Circulation, 2005 Sep 6 , 112 (1494-9).

381

Gómez R et al. Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels.
Br. J. Pharmacol., 2005 Sep , 146 (146-61).

382

Dhoke MA et al. Porous membranes for reconstitution of ion channels.
Biochim. Biophys. Acta, 2005 Oct 15 , 1716 (117-25).

383

Kurata HT et al. Separation of P/C- and U-type inactivation pathways in Kv1.5 potassium channels.
J. Physiol. (Lond.), 2005 Oct 1 , 568 (31-46).

384

Hu Y et al. Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria.
Am. J. Physiol. Heart Circ. Physiol., 2005 Oct , 289 (H1448-55).

385

Liu L et al. Expression and characterization of delayed rectifying K+ channels in anterior rat taste buds.
Am. J. Physiol., Cell Physiol., 2005 Oct , 289 (C868-80).

386

Decher N et al. Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.
Mol. Pharmacol., 2005 Oct , 68 (995-1005).

387

Kato M et al. Evidence for proteasomal degradation of Kv1.5 channel protein.
Biochem. Biophys. Res. Commun., 2005 Nov 11 , 337 (343-8).

388

Barfield JP et al. The effects of putative K+ channel blockers on volume regulation of murine spermatozoa.
Biol. Reprod., 2005 May , 72 (1275-81).

389

Simard C et al. Polymorphism screening in the cardiac K+ channel gene KCNA5.
Clin. Pharmacol. Ther., 2005 Mar , 77 (138-44).

390

Eun JS et al. Open channel block of hKv1.5 by psoralen from Heracleum moellendorffii Hance.
Arch. Pharm. Res., 2005 Mar , 28 (269-73).

391

Yamashita T et al. Cibenzoline attenuates upregulation of Kv1.5 channel gene expression by experimental paroxysmal atrial fibrillation.
, 2005 Mar , 46 (279-88).

392

Wang J et al. Chronic hypoxia inhibits Kv channel gene expression in rat distal pulmonary artery.
Am. J. Physiol. Lung Cell Mol. Physiol., 2005 Jun , 288 (L1049-58).

393

Hotchkiss K et al. Ion channel proteins in mouse and human vestibular tissue.
, 2005 Jun , 132 (916-23).

394

Mobasheri A et al. Quantitative analysis of voltage-gated potassium currents from primary equine (Equus caballus) and elephant (Loxodonta africana) articular chondrocytes.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2005 Jul , 289 (R172-80).

395

Li H et al. KChIP2 modulates the cell surface expression of Kv 1.5-encoded K(+) channels.
J. Mol. Cell. Cardiol., 2005 Jul , 39 (121-32).

396

Persson F et al. Blocking characteristics of hKv1.5 and hKv4.3/hKChIP2.2 after administration of the novel antiarrhythmic compound AZD7009.
J. Cardiovasc. Pharmacol., 2005 Jul , 46 (7-17).

397

Wang T et al. Effect of mitochondrial KATP channel on voltage-gated K+ channel in 24 hour-hypoxic human pulmonary artery smooth muscle cells.
Chin. Med. J., 2005 Jan 5 , 118 (12-9).

398

Zhong CB et al. Delayed rectifier potassium currents and Kv2.1 mRNA increase in hippocampal neurons of scopolamine-induced memory-deficient rats.
Neurosci. Lett., 2005 Jan 10 , 373 (99-104).

399

Brouillette J et al. Sex and strain differences in adult mouse cardiac repolarization: importance of androgens.
Cardiovasc. Res., 2005 Jan 1 , 65 (148-57).

400

Kuryshev YA et al. Pentamidine-induced long QT syndrome and block of hERG trafficking.
J. Pharmacol. Exp. Ther., 2005 Jan , 312 (316-23).

401

Labro AJ et al. Coupling of voltage sensing to channel opening reflects intrasubunit interactions in kv channels.
J. Gen. Physiol., 2005 Jan , 125 (71-80).

402

Plane F et al. Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter.
Circ. Res., 2005 Feb 4 , 96 (216-24).

403

Chung YH et al. Immunohistochemical study on the distribution of the voltage-gated potassium channels in the gerbil cerebellum.
Neurosci. Lett., 2005 Feb 1 , 374 (58-62).

404

Tammaro P et al. Effects of intracellular magnesium on Kv1.5 and Kv2.1 potassium channels.
Eur. Biophys. J., 2005 Feb , 34 (42-51).

405

Guo W et al. Targeted deletion of Kv4.2 eliminates I(to,f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction.
Circ. Res., 2005 Dec 9 , 97 (1342-50).

406

Lan M et al. Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells.
Cancer Biol. Ther., 2005 Dec , 4 (1342-7).

407

Barfield JP et al. Characterization of potassium channels involved in volume regulation of human spermatozoa.
Mol. Hum. Reprod., 2005 Dec , 11 (891-7).

408

Fordyce CB et al. Microglia Kv1.3 channels contribute to their ability to kill neurons.
J. Neurosci., 2005 Aug 3 , 25 (7139-49).

409

Choi WS et al. Kv1.5 surface expression is modulated by retrograde trafficking of newly endocytosed channels by the dynein motor.
Circ. Res., 2005 Aug 19 , 97 (363-71).

410

Choi BH et al. Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents.
Am. J. Physiol., Cell Physiol., 2005 Aug , 289 (C425-36).

411

Herrera D et al. A single residue in the S6 transmembrane domain governs the differential flecainide sensitivity of voltage-gated potassium channels.
Mol. Pharmacol., 2005 Aug , 68 (305-16).

412

Drolet B et al. Human cardiac potassium channel DNA polymorphism modulates access to drug-binding site and causes drug resistance.
J. Clin. Invest., 2005 Aug , 115 (2209-13).

413

Eun JS et al. Effects of oxypeucedanin on hKv1.5 and action potential duration.
Biol. Pharm. Bull., 2005 Apr , 28 (657-60).

414

Cox RH Molecular determinants of voltage-gated potassium currents in vascular smooth muscle.
Cell Biochem. Biophys., 2005 , 42 (167-95).

415

Ahn HS et al. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.
Neuroscience, 2005 , 133 (1007-19).

416

Zhang S et al. Constitutive inactivation of the hKv1.5 mutant channel, H463G, in K+-free solutions at physiological pH.
Cell Biochem. Biophys., 2005 , 43 (221-30).

417

Fedida D et al. Synergistic inhibition of the maximum conductance of Kv1.5 channels by extracellular K+ reduction and acidification.
Cell Biochem. Biophys., 2005 , 43 (231-42).

418

Archer SL et al. O2 sensing in the human ductus arteriosus: redox-sensitive K+ channels are regulated by mitochondria-derived hydrogen peroxide.
Biol. Chem., 2004 Mar-Apr , 385 (205-16).

419

Thébaud B et al. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus.
Circulation, 2004 Sep 14 , 110 (1372-9).

420

Wakisaka Y et al. Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure.
Cardiovasc. Res., 2004 Sep 1 , 63 (689-99).

421

Brevnova EE et al. Overexpression of human KCNA5 increases IK V and enhances apoptosis.
Am. J. Physiol., Cell Physiol., 2004 Sep , 287 (C715-22).

422

Hong Z et al. Subacute hypoxia decreases voltage-activated potassium channel expression and function in pulmonary artery myocytes.
Am. J. Respir. Cell Mol. Biol., 2004 Sep , 31 (337-43).

423

Gögelein H et al. Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2004 Sep , 370 (183-92).

424

Ye H et al. Effect of chronic cigarette smoking on large-conductance calcium-activated potassium channel and Kv1.5 expression in bronchial smooth muscle cells of rats.
, 2004 Oct 25 , 56 (573-8).

425

McMurtry MS et al. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
Circ. Res., 2004 Oct 15 , 95 (830-40).

426

Matsuno N et al. Solid support membranes for ion channel arrays and sensors: application to rapid screening of pharmacological compounds.
Biochim. Biophys. Acta, 2004 Oct 11 , 1665 (184-90).

427

Le Bouter S et al. Long-term amiodarone administration remodels expression of ion channel transcripts in the mouse heart.
Circulation, 2004 Nov 9 , 110 (3028-35).

428

Zhang HX et al. Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels.
Brain Res. Mol. Brain Res., 2004 Nov 24 , 131 (136-40).

429

Zhao LM et al. Effect of passive sensitization by serum from allergic asthmatic patients on the activity and expression of voltage-dependent delayed rectifier potassium channel in human bronchial smooth muscle cells.
Chin. Med. J., 2004 Nov , 117 (1630-6).

430

Rossow CF et al. NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction.
Circ. Res., 2004 May 28 , 94 (1340-50).

431

Kurata HT et al. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
J. Gen. Physiol., 2004 May , 123 (505-20).

432

Peukert S et al. Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel.
Bioorg. Med. Chem. Lett., 2004 Jun 7 , 14 (2823-7).

433

Ferber M et al. Identification of a mammalian target of kappaM-conotoxin RIIIK.
Toxicon, 2004 Jun 15 , 43 (915-21).

434

Brundel BJ et al. Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation.
Cardiovasc. Res., 2004 Jun 1 , 62 (521-8).

435

Vennekamp J et al. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Mol. Pharmacol., 2004 Jun , 65 (1364-74).

436

Pan Y et al. Messenger RNA and protein expression analysis of voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats.
J. Neurosci. Res., 2004 Jul 1 , 77 (94-9).

437

Knobloch K et al. Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
Med. Sci. Monit., 2004 Jul , 10 (BR221-8).

438

Decher N et al. Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels.
J. Biol. Chem., 2004 Jan 2 , 279 (394-400).

439

Li H et al. Selective elimination of I(K,slow1) in mouse ventricular myocytes expressing a dominant negative Kv1.5alpha subunit.
Am. J. Physiol. Heart Circ. Physiol., 2004 Jan , 286 (H319-28).

440

Godreau D et al. [MAGUKs: beyond ionic channel anchoring]
Med Sci (Paris), 2004 Jan , 20 (84-8).

441

Duzhyy DE et al. Cloning and developmental expression of Shaker potassium channels in the cochlea of the chicken.
Brain Res. Mol. Brain Res., 2004 Feb 5 , 121 (70-85).

442

Caballero R et al. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
Cardiovasc. Res., 2004 Dec 1 , 64 (457-66).

443

Vautier F et al. Shaker-type potassium channel subunits differentially control oligodendrocyte progenitor proliferation.
Glia, 2004 Dec , 48 (337-45).

444

Archer SL et al. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells.
Circ. Res., 2004 Aug 6 , 95 (308-18).

445

Brunet S et al. Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles.
J. Physiol. (Lond.), 2004 Aug 15 , 559 (103-20).

446

Gautier P et al. In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects.
J. Cardiovasc. Pharmacol., 2004 Aug , 44 (244-57).

447

Folco EJ et al. Caveolin-3 and SAP97 form a scaffolding protein complex that regulates the voltage-gated potassium channel Kv1.5.
Am. J. Physiol. Heart Circ. Physiol., 2004 Aug , 287 (H681-90).

448

Kwan DC et al. The external K+ concentration and mutations in the outer pore mouth affect the inhibition of kv1.5 current by Ni2+.
Biophys. J., 2004 Apr , 86 (2238-50).

449

Yang EK et al. Altered expression of potassium channel subunit mRNA and alpha-dendrotoxin sensitivity of potassium currents in rat dorsal root ganglion neurons after axotomy.
Neuroscience, 2004 , 123 (867-74).

450

Koren G Electrical remodeling and arrhythmias in long-QT syndrome: lessons from genetic models in mice.
Ann. Med., 2004 , 36 Suppl 1 (22-7).

451

Grunnet M et al. KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels.
Biophys. J., 2003 Sep , 85 (1525-37).

452

Fedida D et al. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.
Circ. Res., 2003 Oct 17 , 93 (744-51).

453

Brendel J et al. Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias.
Curr Med Chem Cardiovasc Hematol Agents, 2003 Oct , 1 (273-87).

454

Vicente R et al. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages.
J. Biol. Chem., 2003 Nov 21 , 278 (46307-20).

455

Godreau D et al. Different isoforms of synapse-associated protein, SAP97, are expressed in the heart and have distinct effects on the voltage-gated K+ channel Kv1.5.
J. Biol. Chem., 2003 Nov 21 , 278 (47046-52).

456

Thornhill WB et al. Molecular cloning and expression of a Kv1.1-like potassium channel from the electric organ of Electrophorus electricus.
J. Membr. Biol., 2003 Nov 1 , 196 (1-8).

457

Zhang S et al. Rapid induction of P/C-type inactivation is the mechanism for acid-induced K+ current inhibition.
J. Gen. Physiol., 2003 Mar , 121 (215-25).

458

Ficker E et al. Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG.
Circ. Res., 2003 Jun 27 , 92 (e87-100).

459

Preussat K et al. Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas.
Neurosci. Lett., 2003 Jul 31 , 346 (33-6).

460

Eldstrom J et al. SAP97 increases Kv1.5 currents through an indirect N-terminal mechanism.
FEBS Lett., 2003 Jul 17 , 547 (205-11).

461

Brunner M et al. In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype.
Am. J. Physiol. Heart Circ. Physiol., 2003 Jul , 285 (H194-203).

462

Brouillette J et al. Effect of androgen deficiency on mouse ventricular repolarization.
J. Physiol. (Lond.), 2003 Jan 15 , 546 (403-13).

463

Soliven B et al. PDGF upregulates delayed rectifier via Src family kinases and sphingosine kinase in oligodendroglial progenitors.
Am. J. Physiol., Cell Physiol., 2003 Jan , 284 (C85-93).

464

Trapani JG et al. Effect of external pH on activation of the Kv1.5 potassium channel.
Biophys. J., 2003 Jan , 84 (195-204).

465

Ma ML et al. Different gene expression of potassium channels by thyroid hormone and an antithyroid drug between the atrium and ventricle of rats.
, 2003 Jan , 44 (101-10).

466

Le Bouter S et al. Microarray analysis reveals complex remodeling of cardiac ion channel expression with altered thyroid status: relation to cellular and integrated electrophysiology.
Circ. Res., 2003 Feb 7 , 92 (234-42).

467

Peukert S et al. Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5.
J. Med. Chem., 2003 Feb 13 , 46 (486-98).

468

Coma M et al. Impaired voltage-gated K+ channel expression in brain during experimental cancer cachexia.
FEBS Lett., 2003 Feb 11 , 536 (45-50).

469

Choe H et al. Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier K+ currents.
J. Pharmacol. Exp. Ther., 2003 Feb , 304 (706-12).

470

Moreno I et al. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
J. Pharmacol. Exp. Ther., 2003 Feb , 304 (862-73).

471

Consiglio JF et al. Influence of pore residues on permeation properties in the Kv2.1 potassium channel. Evidence for a selective functional interaction of K+ with the outer vestibule.
J. Gen. Physiol., 2003 Feb , 121 (111-24).

472

Schroeder K et al. Ionworks HT: a new high-throughput electrophysiology measurement platform.
, 2003 Feb , 8 (50-64).

473

Bru-Mercier G et al. Expression of heart K+ channels in adrenalectomized and catecholamine-depleted reserpine-treated rats.
J. Mol. Cell. Cardiol., 2003 Feb , 35 (153-63).

474

Caouette D et al. Hydrogen peroxide modulates the Kv1.5 channel expressed in a mammalian cell line.
Naunyn Schmiedebergs Arch. Pharmacol., 2003 Dec , 368 (479-86).

475

Watanabe H et al. Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium.
Biochem. Biophys. Res. Commun., 2003 Aug 29 , 308 (439-44).

476

Kodirov SA et al. Long-term restitution of 4-aminopyridine-sensitive currents in Kv1DN ventricular myocytes using adeno-associated virus-mediated delivery of Kv1.5.
FEBS Lett., 2003 Aug 28 , 550 (74-8).

477

Pozeg ZI et al. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats.
Circulation, 2003 Apr 22 , 107 (2037-44).

478

Yamashita T et al. Circadian variation of cardiac K+ channel gene expression.
Circulation, 2003 Apr 15 , 107 (1917-22).

479

Michelakis ED et al. O2 sensing in the human ductus arteriosus: regulation of voltage-gated K+ channels in smooth muscle cells by a mitochondrial redox sensor.
Circ. Res., 2002 Sep 20 , 91 (478-86).

480

Nitabach MN et al. Phosphorylation-dependent and phosphorylation-independent modes of modulation of shaker family voltage-gated potassium channels by SRC family protein tyrosine kinases.
J. Neurosci., 2002 Sep 15 , 22 (7913-22).

481

Pollock NS et al. Expression of voltage-dependent potassium channels in the developing visual system of Xenopus laevis.
J. Comp. Neurol., 2002 Oct 28 , 452 (381-91).

482

Caballero R et al. Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5).
Cardiovasc. Res., 2002 Oct , 56 (104-17).

483

Eldstrom J et al. N-terminal PDZ-binding domain in Kv1 potassium channels.
FEBS Lett., 2002 Nov 20 , 531 (529-37).

484

Knobloch K et al. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
Naunyn Schmiedebergs Arch. Pharmacol., 2002 Nov , 366 (482-7).

485

Bertaso F et al. Expression of voltage-gated K+ channels in human atrium.
Basic Res. Cardiol., 2002 Nov , 97 (424-33).

486

Kehl SJ et al. Molecular determinants of the inhibition of human Kv1.5 potassium currents by external protons and Zn(2+).
J. Physiol. (Lond.), 2002 May 15 , 541 (9-24).

487

Brundel BJ et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation.
Cardiovasc. Res., 2002 May , 54 (380-9).

488

Choi BH et al. Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor.
Am. J. Physiol., Cell Physiol., 2002 Jun , 282 (C1461-8).

489

Drici MD et al. Mice display sex differences in halothane-induced polymorphic ventricular tachycardia.
Circulation, 2002 Jul 23 , 106 (497-503).

490

Thorne GD et al. Hypoxic vasorelaxation inhibition by organ culture correlates with loss of Kv channels but not Ca(2+) channels.
Am. J. Physiol. Heart Circ. Physiol., 2002 Jul , 283 (H247-53).

491

Sadanaga T et al. Decreased 4-aminopyridine sensitive K+ currents in endothelial cells from hypertensive rats.
Hypertens. Res., 2002 Jul , 25 (589-96).

492

Liu Y et al. Tenidap, a novel anti-inflammatory agent, is an opener of the inwardly rectifying K+ channel hKir2.3.
Eur. J. Pharmacol., 2002 Jan 25 , 435 (153-60).

493

Rich TC et al. Mutations throughout the S6 region of the hKv1.5 channel alter the stability of the activation gate.
Am. J. Physiol., Cell Physiol., 2002 Jan , 282 (C161-71).

494

Mason DE et al. Molecular basis of voltage-dependent potassium currents in porcine granulosa cells.
Mol. Pharmacol., 2002 Jan , 61 (201-13).

495

Cox RH Changes in the expression and function of arterial potassium channels during hypertension.
Vascul. Pharmacol., 2002 Jan , 38 (13-23).

496

Chittajallu R et al. Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle.
Proc. Natl. Acad. Sci. U.S.A., 2002 Feb 19 , 99 (2350-5).

497

Smirnov SV et al. Electrophysiologically distinct smooth muscle cell subtypes in rat conduit and resistance pulmonary arteries.
J. Physiol. (Lond.), 2002 Feb 1 , 538 (867-78).

498

Godreau D et al. Mechanisms of action of antiarrhythmic agent bertosamil on hKv1.5 channels and outward potassium current in human atrial myocytes.
J. Pharmacol. Exp. Ther., 2002 Feb , 300 (612-20).

499

Mason HS et al. Modulation of Kv1.5 currents by protein kinase A, tyrosine kinase, and protein tyrosine phosphatase requires an intact cytoskeleton.
Mol. Pharmacol., 2002 Feb , 61 (285-93).

500

Fearon IM et al. O2-sensitive K+ channels in immortalised rat chromaffin-cell-derived MAH cells.
J. Physiol. (Lond.), 2002 Dec 15 , 545 (807-18).

501

Gonzalez T et al. Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels.
Mol. Pharmacol., 2002 Dec , 62 (1456-63).

502

Godreau D et al. Expression, regulation and role of the MAGUK protein SAP-97 in human atrial myocardium.
Cardiovasc. Res., 2002 Dec , 56 (433-42).

503

Kurata HT et al. Amino-terminal determinants of U-type inactivation of voltage-gated K+ channels.
J. Biol. Chem., 2002 Aug 9 , 277 (29045-53).

504

Lu Y et al. Contributions of Kv1.2, Kv1.5 and Kv2.1 subunits to the native delayed rectifier K(+) current in rat mesenteric artery smooth muscle cells.
Life Sci., 2002 Aug 9 , 71 (1465-73).

505

Williams CP et al. Modulation of the human Kv1.5 channel by protein kinase C activation: role of the Kvbeta1.2 subunit.
J. Pharmacol. Exp. Ther., 2002 Aug , 302 (545-50).

506

Wang Z et al. Uncoupling of gating charge movement and closure of the ion pore during recovery from inactivation in the Kv1.5 channel.
J. Gen. Physiol., 2002 Aug , 120 (249-60).

507

Capuano V et al. Ventricular hypertrophy induced by mineralocorticoid treatment or aortic stenosis differentially regulates the expression of cardiac K+ channels in the rat.
Mol. Cell. Biochem., 2002 Aug , 237 (1-10).

508

Jin HW et al. [Effects of chronic exposure to beta-amyloid-peptide25-35 on the mRNA expressions of voltage-gated outward potassium channel subunits in cultured rat hippocampal neurons]
Yao Xue Xue Bao, 2002 Aug , 37 (598-602).

509

Aydar E et al. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit.
Neuron, 2002 Apr 25 , 34 (399-410).

510

Rao JN et al. Activation of K(+) channels and increased migration of differentiated intestinal epithelial cells after wounding.
Am. J. Physiol., Cell Physiol., 2002 Apr , 282 (C885-98).

511

Petrashevskaya NN et al. Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse.
Cardiovasc. Res., 2002 Apr , 54 (117-32).

512

Xu XH et al. [mRNA expressions of voltage-dependent potassium channels in the brain of scopolamine-induced memory impaired rats]
Yao Xue Xue Bao, 2002 Apr , 37 (241-4).

513

Iwasa H et al. Twenty single-nucleotide polymorphisms in four genes encoding cardiac ion channels.
J. Hum. Genet., 2002 , 47 (208-12).

514

Hogg DS et al. Endothelial cells freshly isolated from small pulmonary arteries of the rat possess multiple distinct k+ current profiles.
Lung, 2002 , 180 (203-14).

515

Yu Y et al. c-Jun decreases voltage-gated K(+) channel activity in pulmonary artery smooth muscle cells.
Circulation, 2001 Sep 25 , 104 (1557-63).

516

Perchenet L et al. External nickel blocks human Kv1.5 channels stably expressed in CHO cells.
J. Membr. Biol., 2001 Sep 1 , 183 (51-60).

517

Choi BH et al. Effects of (-)-epigallocatechin-3-gallate, the main component of green tea, on the cloned rat brain Kv1.5 potassium channels.
Biochem. Pharmacol., 2001 Sep 1 , 62 (527-35).

518

Perchenet L et al. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
J. Pharmacol. Exp. Ther., 2001 Sep , 298 (1108-19).

519

Kurata HT et al. Altered state dependence of c-type inactivation in the long and short forms of human Kv1.5.
J. Gen. Physiol., 2001 Sep , 118 (315-32).

520

Longobardo M et al. Bupivacaine effects on hKv1.5 channels are dependent on extracellular pH.
Br. J. Pharmacol., 2001 Sep , 134 (359-69).

521

Michelakis ED et al. The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channels.
Clin. Chest Med., 2001 Sep , 22 (419-32).

522

Horio Y Potassium channels of glial cells: distribution and function.
Jpn. J. Pharmacol., 2001 Sep , 87 (1-6).

523

Malin SA et al. Molecular heterogeneity of the voltage-gated fast transient outward K+ current, I(Af), in mammalian neurons.
J. Neurosci., 2001 Oct 15 , 21 (8004-14).

524

McKay MC et al. Linoleic acid both enhances activation and blocks Kv1.5 and Kv2.1 channels by two separate mechanisms.
Am. J. Physiol., Cell Physiol., 2001 Oct , 281 (C1277-84).

525

Thorneloe KS et al. Molecular composition of 4-aminopyridine-sensitive voltage-gated K(+) channels of vascular smooth muscle.
Circ. Res., 2001 Nov 23 , 89 (1030-7).

526

Kerr PM et al. Heteromultimeric Kv1.2-Kv1.5 channels underlie 4-aminopyridine-sensitive delayed rectifier K(+) current of rabbit vascular myocytes.
Circ. Res., 2001 Nov 23 , 89 (1038-44).

527

Kobayashi S et al. Inhibitory effect of bepridil on hKv1.5 channel current: comparison with amiodarone and E-4031.
Eur. J. Pharmacol., 2001 Nov 2 , 430 (149-57).

528

Steidl JV et al. Distinct mechanisms of block of Kv1.5 channels by tertiary and quaternary amine clofilium compounds.
Biophys. J., 2001 Nov , 81 (2606-13).

529

Wang Z et al. Gating charge immobilization caused by the transition between inactivated states in the Kv1.5 channel.
Biophys. J., 2001 Nov , 81 (2614-27).

530

McDaniel SS et al. Anorexic effect of K+ channel blockade in mesenteric arterial smooth muscle and intestinal epithelial cells.
J. Appl. Physiol., 2001 Nov , 91 (2322-33).

531

Li H et al. Functional expression of a GFP-tagged Kv1.5 alpha-subunit in mouse ventricle.
Am. J. Physiol. Heart Circ. Physiol., 2001 Nov , 281 (H1955-67).

532

Huang B et al. Spatial alterations of Kv channels expression and K(+) currents in post-MI remodeled rat heart.
Cardiovasc. Res., 2001 Nov , 52 (246-54).

533

Bachmann A et al. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Naunyn Schmiedebergs Arch. Pharmacol., 2001 Nov , 364 (472-8).

534

London B et al. Targeted replacement of KV1.5 in the mouse leads to loss of the 4-aminopyridine-sensitive component of I(K,slow) and resistance to drug-induced qt prolongation.
Circ. Res., 2001 May 11 , 88 (940-6).

535

Cox RH et al. Differential expression of voltage-gated K(+) channel genes in arteries from spontaneously hypertensive and Wistar-Kyoto rats.
Hypertension, 2001 May , 37 (1315-22).

536

Chung S et al. Beta-amyloid peptide induces the expression of voltage dependent outward rectifying K+ channels in rat microglia.
Neurosci. Lett., 2001 Mar 9 , 300 (67-70).

537

Chung YH et al. Immunohistochemical study on the distribution of six members of the Kv1 channel subunits in the rat cerebellum.
Brain Res., 2001 Mar 23 , 895 (173-7).

538

Martens JR et al. Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae.
J. Biol. Chem., 2001 Mar 16 , 276 (8409-14).

539

Matsuda T et al. Inhibition by a novel anti-arrhythmic agent, NIP-142, of cloned human cardiac K+ channel Kv1.5 current.
Life Sci., 2001 Mar 16 , 68 (2017-24).

540

Lu Y et al. Modulation of voltage-dependent K+ channel current in vascular smooth muscle cells from rat mesenteric arteries.
J. Membr. Biol., 2001 Mar 15 , 180 (163-75).

541

Brundel BJ et al. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels.
J. Am. Coll. Cardiol., 2001 Mar 1 , 37 (926-32).

542

Lin S et al. Influence of permeating ions on Kv1.5 channel block by nifedipine.
Am. J. Physiol. Heart Circ. Physiol., 2001 Mar , 280 (H1160-72).

543

Bähring R et al. Coupling of voltage-dependent potassium channel inactivation and oxidoreductase active site of Kvbeta subunits.
J. Biol. Chem., 2001 Jun 22 , 276 (22923-9).

544

Hatton WJ et al. Functional and molecular expression of a voltage-dependent K(+) channel (Kv1.1) in interstitial cells of Cajal.
J. Physiol. (Lond.), 2001 Jun 1 , 533 (315-27).

545

Cukovic D et al. A discrete amino terminal domain of Kv1.5 and Kv1.4 potassium channels interacts with the spectrin repeats of alpha-actinin-2.
FEBS Lett., 2001 Jun 1 , 498 (87-92).

546

Reeve HL et al. Alterations in a redox oxygen sensing mechanism in chronic hypoxia.
J. Appl. Physiol., 2001 Jun , 90 (2249-56).

547

Ekhterae D et al. Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2001 Jul , 281 (C157-65).

548

Kuryshev YA et al. KChAP/Kvbeta1.2 interactions and their effects on cardiac Kv channel expression.
Am. J. Physiol., Cell Physiol., 2001 Jul , 281 (C290-9).

549

Coppock EA et al. Molecular basis of hypoxia-induced pulmonary vasoconstriction: role of voltage-gated K+ channels.
Am. J. Physiol. Lung Cell Mol. Physiol., 2001 Jul , 281 (L1-12).

550

Zhang S et al. Modulation of Kv1.5 potassium channel gating by extracellular zinc.
Biophys. J., 2001 Jul , 81 (125-36).

551

Patel AJ et al. Molecular physiology of oxygen-sensitive potassium channels.
Eur. Respir. J., 2001 Jul , 18 (221-7).

552

Nitabach MN et al. A mechanism for combinatorial regulation of electrical activity: Potassium channel subunits capable of functioning as Src homology 3-dependent adaptors.
Proc. Natl. Acad. Sci. U.S.A., 2001 Jan 16 , 98 (705-10).

553

Jäger H et al. Regulation of a mammalian Shaker-related potassium channel, hKv1.5, by extracellular potassium and pH.
FEBS Lett., 2001 Jan 12 , 488 (45-50).

554

González T et al. Stereoselective effects of the enantiomers of a new local anaesthetic, IQB-9302, on a human cardiac potassium channel (Kv1.5).
Br. J. Pharmacol., 2001 Jan , 132 (385-92).

555

Brundel BJ et al. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation.
Circulation, 2001 Feb 6 , 103 (684-90).

556

González T et al. Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels.
J. Pharmacol. Exp. Ther., 2001 Feb , 296 (573-83).

557

Fathi H B et al. The facilitatory actions of snake venom phospholipase A(2) neurotoxins at the neuromuscular junction are not mediated through voltage-gated K(+) channels.
Toxicon, 2001 Dec , 39 (1871-82).

558

Murata M et al. SAP97 interacts with Kv1.5 in heterologous expression systems.
Am. J. Physiol. Heart Circ. Physiol., 2001 Dec , 281 (H2575-84).

559

Coppock EA et al. Differential expression of K(V) channel alpha- and beta-subunits in the bovine pulmonary arterial circulation.
Am. J. Physiol. Lung Cell Mol. Physiol., 2001 Dec , 281 (L1350-60).

560

Trépanier-Boulay V et al. Gender-based differences in cardiac repolarization in mouse ventricle.
Circ. Res., 2001 Aug 31 , 89 (437-44).

561

Archer SL et al. Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5.
FASEB J., 2001 Aug , 15 (1801-3).

562

Iftinca M et al. State-dependent block of rabbit vascular smooth muscle delayed rectifier and Kv1.5 channels by inhibitors of cytochrome P450-dependent enzymes.
J. Pharmacol. Exp. Ther., 2001 Aug , 298 (718-28).

563

Andrews EM et al. Voltage-gated K+ channels in chemoreceptor sensory neurons of rat petrosal ganglion.
Brain Res., 2001 Apr 6 , 897 (199-203).

564

Zhang S et al. External K(+) relieves the block but not the gating shift caused by Zn(2+) in human Kv1.5 potassium channels.
J. Physiol. (Lond.), 2001 Apr 15 , 532 (349-58).

565

Platoshyn O et al. Chronic hypoxia decreases K(V) channel expression and function in pulmonary artery myocytes.
Am. J. Physiol. Lung Cell Mol. Physiol., 2001 Apr , 280 (L801-12).

566

Khanna R et al. K+ channels and the microglial respiratory burst.
Am. J. Physiol., Cell Physiol., 2001 Apr , 280 (C796-806).

567

Caballero R et al. Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.
Mol. Pharmacol., 2001 Apr , 59 (825-36).

568

Fernandez M et al. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder.
Ann. Neurol., 2001 Apr , 49 (486-92).

569

Su J et al. The expression and regulation of depolarization-activated K+ channels in the insulin-secreting cell line INS-1.
Pflugers Arch., 2001 Apr , 442 (49-56).

570

Davies AR et al. Kv channel subunit expression in rat pulmonary arteries.
Lung, 2001 , 179 (147-61).

571

Michelakis ED et al. Gene transfer and metabolic modulators as new therapies for pulmonary hypertension. Increasing expression and activity of potassium channels in rat and human models.
Adv. Exp. Med. Biol., 2001 , 502 (401-18).

572

Yue L et al. Molecular evidence for a role of Shaw (Kv3) potassium channel subunits in potassium currents of dog atrium.
J. Physiol. (Lond.), 2000 Sep 15 , 527 Pt 3 (467-78).

573

Braun AP et al. Inhibition of a mammalian large conductance, calcium-sensitive K+ channel by calmodulin-binding peptides.
J. Physiol. (Lond.), 2000 Sep 15 , 527 Pt 3 (479-92).

574

Yang IC et al. Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.
J. Pharmacol. Exp. Ther., 2000 Sep , 294 (955-62).

575

Vianna-Jorge R et al. Correolide, a nor-triterpenoid blocker of Shaker-type Kv1 channels elicits twitches in guinea-pig ileum by stimulating the enteric nervous system and enhancing neurotransmitter release.
Br. J. Pharmacol., 2000 Oct , 131 (772-8).

576

Perchenet L et al. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
J. Pharmacol. Exp. Ther., 2000 Nov , 295 (771-8).

577

Wang Z et al. A high-Na(+) conduction state during recovery from inactivation in the K(+) channel Kv1.5.
Biophys. J., 2000 Nov , 79 (2416-33).

578

van der Velden HMW et al. Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization.
J. Cardiovasc. Electrophysiol., 2000 Nov , 11 (1262-9).

579

Maruoka ND et al. alpha-actinin-2 couples to cardiac Kv1.5 channels, regulating current density and channel localization in HEK cells.
FEBS Lett., 2000 May 12 , 473 (188-94).

580

Choi BH et al. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells.
J. Pharmacol. Exp. Ther., 2000 May , 293 (634-40).

581

Longobardo M et al. Effects of a quaternary bupivacaine derivative on delayed rectifier K(+) currents.
Br. J. Pharmacol., 2000 May , 130 (391-401).

582

Kang J et al. High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide.
Eur. J. Pharmacol., 2000 Mar 31 , 392 (137-40).

583

Osipenko ON et al. Potential role for kv3.1b channels as oxygen sensors.
Circ. Res., 2000 Mar 17 , 86 (534-40).

584

Wang Z et al. Regulation of transient Na+ conductance by intra- and extracellular K+ in the human delayed rectifier K+ channel Kv1.5.
J. Physiol. (Lond.), 2000 Mar 15 , 523 Pt 3 (575-91).

585

Caballero R et al. Losartan and its metabolite E3174 modify cardiac delayed rectifier K(+) currents.
Circulation, 2000 Mar 14 , 101 (1199-205).

586

Wulfsen I et al. Expression of mRNA for voltage-dependent and inward-rectifying K channels in GH3/B6 cells and rat pituitary.
J. Neuroendocrinol., 2000 Mar , 12 (263-72).

587

Dobrzynski H et al. Presence of the Kv1.5 K(+) channel in the sinoatrial node.
J. Histochem. Cytochem., 2000 Jun , 48 (769-80).

588

Grammer JB et al. Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation.
J. Cardiovasc. Electrophysiol., 2000 Jun , 11 (626-33).

589

Zhang TT et al. TRH regulates Kv1.5 gene expression through a Galphaq-mediated PLC-independent pathway.
Mol. Cell. Endocrinol., 2000 Jul 25 , 165 (33-9).

590

MacFarlane SN et al. Modulation of Kv1.5 currents by Src tyrosine phosphorylation: potential role in the differentiation of astrocytes.
J. Neurosci., 2000 Jul 15 , 20 (5245-53).

591

Rolf S et al. Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes.
Naunyn Schmiedebergs Arch. Pharmacol., 2000 Jul , 362 (22-31).

592

Hershman KM et al. RPTPmu and protein tyrosine phosphorylation regulate K(+) channel mRNA expression in adult cardiac myocytes.
Am. J. Physiol., Cell Physiol., 2000 Feb , 278 (C397-403).

593

Bou-Abboud E et al. Molecular diversity of the repolarizing voltage-gated K+ currents in mouse atrial cells.
J. Physiol. (Lond.), 2000 Dec 1 , 529 Pt 2 (345-58).

594

Ojamaa K et al. Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat.
Am. J. Physiol. Endocrinol. Metab., 2000 Dec , 279 (E1319-24).

595

Frey BW et al. Blocking of cloned and native delayed rectifier K channels from visceral smooth muscles by phencyclidine.
Neurogastroenterol. Motil., 2000 Dec , 12 (509-16).

596

Zhabyeyev P et al. Low-affinity block of cardiac K(+) currents by nifedipine.
Eur. J. Pharmacol., 2000 Aug 4 , 401 (137-43).

597

Peretz A et al. Hypomyelination and increased activity of voltage-gated K(+) channels in mice lacking protein tyrosine phosphatase epsilon.
EMBO J., 2000 Aug 1 , 19 (4036-45).

598

Yamashita T et al. Short-term effects of rapid pacing on mRNA level of voltage-dependent K(+) channels in rat atrium: electrical remodeling in paroxysmal atrial tachycardia.
Circulation, 2000 Apr 25 , 101 (2007-14).

599

Xu C et al. Molecular basis of voltage-dependent delayed rectifier K+ channels in smooth muscle cells from rat tail artery.
Life Sci., 2000 Apr 14 , 66 (2023-33).

600

Archer SL et al. Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation.
Adv. Exp. Med. Biol., 2000 , 475 (219-40).

601

Xu DH et al. [The expression of arrhythmic related genes on Xenopus oocytes for evaluation of class III antiarrhythmic drugs from ocean active material]
Yi Chuan Xue Bao, 2000 , 27 (195-201).

602

Kwak YG et al. Phosphorylation is required for alteration of kv1.5 K(+) channel function by the Kvbeta1.3 subunit.
J. Biol. Chem., 1999 Sep 3 , 274 (25355-61).

603

Hulme JT et al. Oxygen sensitivity of cloned voltage-gated K(+) channels expressed in the pulmonary vasculature.
Circ. Res., 1999 Sep 17 , 85 (489-97).

604

Peretz A et al. Tyrosine kinases modulate K+ channel gating in mouse Schwann cells.
J. Physiol. (Lond.), 1999 Sep 1 , 519 Pt 2 (373-84).

605

Schmidt K et al. Heterogeneous expression of voltage-gated potassium channels of the shaker family (Kv1) in oligodendrocyte progenitors.
Brain Res., 1999 Oct 2 , 843 (145-60).

606

Wade GR et al. Delayed rectifier and Ca(2+)-dependent K(+) currents in human esophagus: roles in regulating muscle contraction.
Am. J. Physiol., 1999 Oct , 277 (G885-95).

607

Caballero R et al. Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.
Br. J. Pharmacol., 1999 Nov , 128 (1071-81).

608

Xu C et al. Expression of voltage-dependent K(+) channel genes in mesenteric artery smooth muscle cells.
Am. J. Physiol., 1999 Nov , 277 (G1055-63).

609

Lee JK et al. Downregulation of voltage-gated K(+) channels in rat heart with right ventricular hypertrophy.
Am. J. Physiol., 1999 Nov , 277 (H1725-31).

610

Hesketh JC et al. Sequential gating in the human heart K(+) channel Kv1.5 incorporates Q(1) and Q(2) charge components.
Am. J. Physiol., 1999 Nov , 277 (H1956-66).

611

Kwak YG et al. Protein kinase A phosphorylation alters Kvbeta1.3 subunit-mediated inactivation of the Kv1.5 potassium channel.
J. Biol. Chem., 1999 May 14 , 274 (13928-32).

612

Vigdor-Alboim S et al. Discoordinate regulation of different K channels in cultured rat skeletal muscle by nerve growth factor.
J. Neurosci. Res., 1999 May 1 , 56 (275-83).

613

Steidl JV et al. Differential sensitivity of voltage-gated potassium channels Kv1.5 and Kv1.2 to acidic pH and molecular identification of pH sensor.
Mol. Pharmacol., 1999 May , 55 (812-20).

614

Delpón E et al. Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5).
Cardiovasc. Res., 1999 May , 42 (510-20).